15428	Noncontraceptive uses of hormonal contraceptives	Women at risk for or with conditions that might benefit from noncontraceptive use of hormonal contraceptive drugs
37920	ACR Appropriateness Criteria&amp;reg; neuroendocrine imaging	Patients with endocrine disorders
38409	Lower limb peripheral arterial disease: diagnosis and management	"Adults aged 18 and older, including:&lt;/p&gt;\\r\\n&lt;ul style=&quot;list-style-type: disc;&quot;&gt;\\r\\n    &lt;li&gt;People who present with symptoms of lower limb peripheral arterial disease (PAD), including intermittent claudication, ischaemic rest pain, and/or tissue loss &lt;/li&gt;\\r\\n    &lt;li&gt;People without symptoms of peripheral arterial disease (for example, those with venous ulceration) who have abnormal ankle/brachial pressure index (ABPI) &lt;/li&gt;\\r\\n    &lt;li&gt;Subgroups based on ethnicity, socioeconomic factors, age, or comorbidities (including people with diabetes), for which differences in management and outcome are identified &lt;/li&gt;\\r\\n&lt;/ul&gt;\\r\\n&lt;p class=&quot;Note&quot;&gt;&lt;strong&gt;Note&lt;/strong&gt;: These guidelines are not intended for use in the following patients:&lt;/p&gt;\\r\\n&lt;ul class=&quot;contentListFont&quot;&gt;\\r\\n    &lt;li&gt;Children and young people aged 17 and younger &lt;/li&gt;\\r\\n    &lt;li&gt;Adults who have acute ischaemia of the lower limb &lt;/li&gt;\\r\\n&lt;/ul&gt;&lt;/div&gt;"
48763	Energy expenditure: measuring resting metabolic rate (RMR) in the critically ill evidence-based nutrition practice guideline	"Critically ill patients (children and adults, 2 to 79 years of age) requiring or eligible for nutrition support in the intensive care unit (ICU)&lt;/p&gt;\\n&lt;p class=&quot;Note&quot;&gt;&lt;strong&gt;Note&lt;/strong&gt;: The evidence for the guideline did not specifically examine populations that were exclusively patients with burns, although many of the principles may apply. Some of the principles may apply to pediatric populations, but the evidence in this patient group was limited in the current project."
43766	"Preventive activities prior to pregnancy. In: Guidelines for preventive activities in general practice, 8th edition"	Australian women aged 15 to 49 years
10584	Management of stable angina. A national clinical guideline	"Adult patients with stable angina&lt;/p&gt;\\r\\n\\r\\n&lt;p&gt;&lt;strong&gt;Note&lt;/strong&gt;: Patients who have unstable angina (acute coronary syndrome) are outside the remit of this guideline, as these patients usually require more urgent and immediate management."
10585	Acute coronary syndromes. A national clinical guideline	Adult patients with acute coronary syndromes (ACS)
10587	Management of chronic heart failure. A national clinical guideline	Adult patients with chronic heart failure
12379	Delirium and acute problematic behavior in the long-term care setting	Elderly residents of long-term care facilities with delirium or acute problematic behavior
13575	Guide to the care of the hospitalized patient with ischemic stroke. 2nd edition	&lt;ul style=&quot;list-style-type: disc;&quot;&gt;\\r\\n    &lt;li&gt;Person presenting in field or emergency department with suspected or known ischemic stroke &lt;/li&gt;\\r\\n    &lt;li&gt;Hospitalized patients with suspected or known ischemic stroke&lt;/li&gt;\\r\\n&lt;/ul&gt;
14328	Stroke. Diagnosis and initial management of acute stroke and transient ischaemic attack (TIA)	"People with transient ischaemic attacks (TIAs) or completed strokes; that is, an acute neurological event presumed to be vascular in origin and causing cerebral ischaemia, cerebral infarction or cerebral haemorrhage.&lt;/p&gt;\\r\\n\\r\\n&lt;p&gt;This includes:&lt;/p&gt;\\r\\n&lt;ul type=&quot;disc&quot;&gt;\\r\\n    &lt;li&gt;First and recurrent events &lt;/li&gt;\\r\\n    &lt;li&gt;Thrombotic and embolic events &lt;/li&gt;\\r\\n    &lt;li&gt;Primary intracerebral haemorrhage of any cause, including venous thrombosis &lt;/li&gt;\\r\\n&lt;/ul&gt;\\r\\n\\r\\n&lt;p&gt;Groups that are not covered:&lt;/p&gt;\\r\\n\\r\\n&lt;ul type=&quot;disc&quot;&gt;\\r\\n    &lt;li&gt;People with subarachnoid haemorrhage &lt;/li&gt;\\r\\n    &lt;li&gt;Children (aged 16 years and under) &lt;/li&gt;\\r\\n&lt;/ul&gt;&lt;/div&gt;"
14329	Identification and management of familial hypercholesterolaemia	"Adults and children with possible or definite heterozygous or homozygous familial hypocholesterolaemia in the National Health Service (NHS) in England and Wales&lt;/p&gt;\\r\\n&lt;p class=&quot;Note&quot;&gt;&lt;strong&gt;Note&lt;/strong&gt;: Groups not covered include:&lt;/p&gt;\\r\\n&lt;ul class=&quot;contentListFont&quot;&gt;\\r\\n    &lt;li&gt;People with secondary hyperlipidaemia &lt;/li&gt;\\r\\n    &lt;li&gt;People with polygenic and combined hyperlipidaemia &lt;/li&gt;\\r\\n    &lt;li&gt;People with hypertriglyceridaemia and type III hyperlipoproteinaemia &lt;/li&gt;\\r\\n    &lt;li&gt;Children with other abnormalities of lipid metabolism, such as sitosterolaemia or phytosterolemia &lt;/li&gt;\\r\\n&lt;/ul&gt;&lt;/div&gt;"
15290	Occupational therapy practice guidelines for adults with stroke	Adult stroke survivors
15488	American Academy of Orthopaedic Surgeons clinical practice guideline on the treatment of glenohumeral joint osteoarthritis	Adults (19 years of age and older) with osteoarthritis of the glenohumeral joint
15596	Non-pharmaceutical management of depression in adults. A national clinical guideline	Adults 18 years or older with depression
15597	Management of obesity. A national clinical guideline	"Children, young people, and adults with overweight and obesity"
15695	Putting evidence into practice: interventions for depression	Patients with cancer-related depression
15711	Clinical practice guideline on the management of lipids as a cardiovascular risk factor	"Individuals at increased risk for cardiovascular disease (CVD)&lt;/p&gt;\\r\\n&lt;p class=&quot;Note&quot;&gt;&lt;strong&gt;Note&lt;/strong&gt;: This guideline does not address:&lt;/p&gt;\\r\\n&lt;ul class=&quot;contentListFont&quot;&gt;\\r\\n    &lt;li&gt;The management of individuals with familial hypercholesterolemia and other genetic dyslipidemias &lt;/li&gt;\\r\\n    &lt;li&gt;Other cardiovascular risk factors such as smoking, high blood pressure, and diabetes &lt;/li&gt;\\r\\n&lt;/ul&gt;&lt;/div&gt;"
15712	Clinical practice guidelines on arterial hypertension. 2007 update	"Adult patients with hypertension&lt;/p&gt;\\r\\n&lt;p class=&quot;Note&quot;&gt;&lt;strong&gt;Note&lt;/strong&gt;: This guideline does not address childhood arterial hypertension (AHT), AHT during pregnancy, or the study of secondary AHT."
15853	Practice parameter update: evaluation and management of driving risk in dementia. Report of the Quality Standards Subcommittee of the American Academy of Neurology	Patients with dementia
16319	Asthma	"Children, adolescents, and adults with asthma"
16321	Occupational therapy practice guidelines for adults with Alzheimer\'s disease and related disorders	Adults with Alzheimer\\\'s disease and related disorders and their caregivers
16392	Chest pain of recent onset: assessment and diagnosis of recent onset chest pain or discomfort of suspected cardiac origin	"Adults who have recent onset chest pain or discomfort of suspected cardiac origin, with or without a prior history and/or diagnosis of cardiovascular disease"
16393	Unstable angina and NSTEMI: the early management of unstable angina and non-ST-segment-elevation myocardial infarction	"Adults (18 years and older), with a diagnosis of unstable angina or non-ST elevation MI (NSTEMI)"
16394	Management of diabetes. A national clinical guideline	"&lt;ul style=&quot;list-style-type: disc;&quot;&gt;\\r\\n    &lt;li&gt;Children and adults with diabetes mellitus, type 1 or type 2 &lt;/li&gt;\\r\\n    &lt;li&gt;Pregnant women with gestational diabetes &lt;/li&gt;\\r\\n&lt;/ul&gt;"
16396	Obesity in pregnancy	Obese women considering pregnancy and obese pregnant women
23801	Chronic obstructive pulmonary disease. Management of chronic obstructive pulmonary disease in adults in primary and secondary care	Adults who have a clinical working diagnosis of chronic obstructive pulmonary disease (COPD)
23824	ACR Appropriateness Criteria&amp;reg; osteoporosis and bone mineral density	Patients at risk of developing osteoporosis
23848	Management of patients with stroke: identification and management of dysphagia. A national clinical guideline	"Stroke patients in Scotland throughout the care pathway from initial primary care response, through hospital admission, on to continuing care in the community. The emphasis is on patients in the acute setting.&lt;/p&gt;\\n&lt;p class=&quot;Note&quot;&gt;&lt;strong&gt;Note&lt;/strong&gt;: The guideline does not apply to people with neurological conditions other than stroke or to people with subarachnoid haemorrhage."
23849	"Management of patients with stroke: rehabilitation, prevention and management of complications, and discharge planning. A national clinical guideline"	Adult patients with stroke
23860	Chronic obstructive pulmonary disease	Adults with chronic obstructive pulmonary disease (COPD)
23899	"Prevention of ventricular remodeling, cardiac dysfunction, and heart failure: HFSA 2010 comprehensive heart failure practice guideline"	"Patients with conditions that predispose them to ventricular remodeling, cardiac dysfunction, and heart failure"
23900	Evaluation of patients for ventricular dysfunction and heart failure: HFSA 2010 comprehensive heart failure practice guideline	&lt;ul style=&quot;list-style-type: disc;&quot;&gt;\\r\\n    &lt;li&gt;Patients at risk of developing heart failure (HF) &lt;/li&gt;\\r\\n    &lt;li&gt;Patients suspected of having HF based on signs and symptoms or incidental evidence of abnormal cardiac structure or function &lt;/li&gt;\\r\\n    &lt;li&gt;Patients with established symptomatic heart failure &lt;/li&gt;\\r\\n&lt;/ul&gt;
23901	Management of asymptomatic patients with reduced left ventricular ejection fraction: HFSA 2010 comprehensive heart failure practice guideline	Patients with asymptomatic reduced left ventricular ejection fraction
23902	Nonpharmacologic management and health care maintenance of patients with chronic heart failure: HFSA 2010 comprehensive heart failure practice guideline	Patients with chronic heart failure
23903	Heart failure in patients with reduced ejection fraction: HFSA 2010 comprehensive heart failure practice guideline	Patients with heart failure patients&amp;nbsp;and reduced ejection fraction
23904	"Disease management, advance directives, and end-of-life care in heart failure: HFSA 2010 comprehensive heart failure practice guideline"	Patients with heart failure
23905	Electrophysiology testing and the use of devices in heart failure: HFSA 2010 comprehensive heart failure practice guideline	Patients with heart failure
23906	Surgical approaches to the treatment of heart failure: HFSA 2010 comprehensive heart failure practice guideline	Patients with heart failure who are candidates for surgical treatment
23907	Evaluation and management of patients with heart failure and preserved left ventricular ejection fraction: HFSA 2010 comprehensive heart failure practice guideline	Patients with heart failure with preserved left ventricular ejection fraction
23908	Evaluation and management of patients with acute decompensated heart failure: HFSA 2010 comprehensive heart failure practice guideline	Patients with acute decompensated heart failure (ADHF)
23909	Evaluation and therapy for heart failure in the setting of ischemic heart disease: HFSA 2010 comprehensive heart failure practice guideline	Patients with heart failure due to coronary artery disease (CAD)
23910	Managing patients with hypertension and heart failure: HFSA 2010 comprehensive heart failure practice guideline	Patients with hypertension and heart failure
23911	Management of heart failure in special populations: HFSA 2010 comprehensive heart failure practice guideline	"Elderly patients, women, and African Americans with heart failure"
23912	Myocarditis: current treatment: HFSA 2010 comprehensive heart failure practice guideline	Patients with confirmed or suspected myocarditis
23913	Genetic evaluation of cardiomyopathy: HFSA 2010 comprehensive heart failure practice guideline	"Patients and their blood relatives with, or at risk for, cardiomyopathy"
23924	Chronic kidney disease evidence-based nutrition practice guideline	Adults diagnosed with chronic kidney disease
23992	Endotracheal suctioning of mechanically ventilated patients with artificial airways 2010	Mechanically ventilated adults and children with artificial airways
24049	"Healthy eating, physical activity, and healthy weights guideline for public health in Ontario"	Ontario adults and children
24110	Certolizumab pegol for the treatment of rheumatoid arthritis	Patients with rheumatoid arthritis
24111	"Adalimumab, etanercept, infliximab, rituximab and abatacept for the treatment of rheumatoid arthritis after the failure of a TNF inhibitor"	"Adults with severe active rheumatoid arthritis who have had an inadequate response to, or are intolerant of, other disease-modifying anti-rheumatic drugs (DMARDs), including at least one tumor necrosis factor (TNF) inhibitor"
24113	Dronedarone for the treatment of non-permanent atrial fibrillation	"Patients with non-permanent atrial fibrillation whose atrial fibrillation is not controlled by first-line therapy (usually including beta-blockers), who do not have unstable New York Heart Association (NYHA) class III or IV heart failure, and who have at least one of the following cardiovascular risk factors:&lt;/p&gt;\\r\\n&lt;ul style=&quot;list-style-type: disc;&quot;&gt;\\r\\n    &lt;li&gt;Hypertension requiring drugs of at least two different classes &lt;/li&gt;\\r\\n    &lt;li&gt;Diabetes mellitus &lt;/li&gt;\\r\\n    &lt;li&gt;Previous transient ischaemic attack, stroke, or systemic embolism &lt;/li&gt;\\r\\n    &lt;li&gt;Left atrial diameter of 50 mm or greater &lt;/li&gt;\\r\\n    &lt;li&gt;Left ventricular ejection fraction less than 40% &lt;/li&gt;\\r\\n    &lt;li&gt;Age 70 years or older &lt;/li&gt;\\r\\n&lt;/ul&gt;&lt;/div&gt;"
24120	Chronic heart failure. Management of chronic heart failure in adults in primary and secondary care	Adult patients (aged 18 years or older) who have symptoms or a diagnosis of chronic heart failure&lt;/p&gt;\\r\\n&lt;p class=&quot;Note&quot;&gt;&lt;strong&gt;Note&lt;/strong&gt;: The following groups will not be covered:&lt;/p&gt;\\r\\n&lt;ul class=&quot;contentListFont&quot;&gt;\\r\\n    &lt;li&gt;Patients with right heart failure as a consequence of respiratory disease &lt;/li&gt;\\r\\n    &lt;li&gt;Pregnant women &lt;/li&gt;\\r\\n&lt;/ul&gt;&lt;/div&gt;
24127	AAFP guideline for the detection and management of post-myocardial infarction depression	"Patients who have sustained ST-elevation myocardial infarction (STEMI) or non&amp;ndash;ST-elevation myocardial infarction (NSTEMI)&lt;/p&gt;\\r\\n&lt;p class=&quot;Note&quot;&gt;&lt;strong&gt;Note&lt;/strong&gt;: Patients with unstable angina and those with acute coronary syndrome relieved by revascularization (thrombolysis, angioplasty, or bypass surgery) have not been included in studies to date. The studies available do not generally distinguish between STEMI and NSTEMI."
24158	"Practice guideline for the treatment of patients with major depressive disorder, third edition"	Individuals with major depressive disorder
24167	Evidence-based guideline: the role of diffusion and perfusion MRI for the diagnosis of acute ischemic stroke. Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology	Patients with possible acute ischemic stroke
24168	Organisation of services. In: Clinical guidelines for stroke management 2010	Adults (18 years or older) with stroke or transient ischemic attack (TIA) symptoms
24169	Stroke recognition and pre-hospital care. In: Clinical guidelines for stroke management 2010	Adults (18 years or older) with stroke or transient ischemic attack (TIA) symptoms
24170	Early assessment and diagnosis. In: Clinical guidelines for stroke management 2010	Adults (18 years or older) with stroke or transient ischemic attack (TIA) symptoms
24171	Acute medical and surgical management. In: Clinical guidelines for stroke management 2010	Adults (18 years or older) with stroke or transient ischemic attack (TIA) symptoms
24172	Secondary prevention. In: Clinical guidelines for stroke management 2010	Adults (18 years or older) with stroke or transient ischemic attack (TIA) symptoms
24173	Rehabilitation. In: Clinical guidelines for stroke management 2010	Adults (18 years or older) with stroke or transient ischemic attack (TIA) symptoms
24174	Managing complications. In: Clinical guidelines for stroke management 2010	Adults (18 years or older) with stroke or transient ischemic attack (TIA) symptoms
24175	Community participation and long-term recovery. In: Clinical guidelines for stroke management 2010	Adults (18 years or older) with stroke or transient ischemic attack (TIA) symptoms
24176	"Guideline recommendations and their rationales for the treatment of adult patients. In: Shared decision-making in the appropriate initiation of and withdrawal from dialysis, 2nd edition"	"Adult patients with acute kidney injury, stage 4 or 5 chronic kidney disease, or end-stage renal disease"
24192	VA/DoD clinical practice guideline for the management of diabetes mellitus	Adult patients (18 years or older) with diabetes mellitus receiving treatment in the Department of Veterans Affairs (VA) or Department of Defense (DoD) healthcare system
24513	Warfarin therapy management	Adult patients 19 years and older in British Columbia who require warfarin therapy
24594	Guidelines for the practice of diabetes education	Individuals with type 1 and 2 diabetes
24599	Allergic Rhinitis and its Impact on Asthma (ARIA) 2010 revision	"Adults and children with allergy, allergic rhinitis, and/or asthma"
24712	Treatment of dyslipidaemias	"&lt;ul style=&quot;list-style-type: disc;&quot;&gt;\\r\\n    &lt;li&gt;Patients with ischemic heart disease, other atherosclerotic diseases (cerebrovascular disease, peripheral arterial disease) or diabetes &lt;/li&gt;\\r\\n    &lt;li&gt;Symptomless individuals with or at high risk for dyslipidemia &lt;/li&gt;\\r\\n&lt;/ul&gt;"
24713	Coronary heart disease	"Persons with suspected or confirmed coronary heart disease, including those with stable angina"
24798	American Academy of Orthopaedic Surgeons clinical practice guideline on the treatment of symptomatic osteoporotic spinal compression fractures	Adults (defined as patients 18 years of age and older) with symptomatic osteoporotic spinal compression fractures
25310	2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines	"Adults age 20 and older who are asymptomatic for cardiovascular disease (CVD)&lt;/p&gt;\\r\\n&lt;p class=&quot;Note&quot;&gt;&lt;strong&gt;Note&lt;/strong&gt;: This guideline specifically excludes from consideration patients with a diagnosis of CVD or a coronary event, for example, angina or anginal equivalent, myocardial infarction, or revascularization with percutaneous coronary intervention or coronary artery bypass graft surgery."
25311	Endocrine and nutritional management of the post-bariatric surgery patient: an Endocrine Society clinical practice guideline	"Patients in the immediate postoperative period who have undergone bariatric surgery for obesity, including those with diabetes mellitus"
25316	Screening for osteoporosis: U.S. Preventive Services Task Force recommendation statement	"Older adults in the general U.S. population who do not have a history of an osteoporotic fracture, osteoporosis secondary to another condition, or other specific clinical indications for bone measurement testing&lt;/p&gt;\\r\\n&lt;p class=&quot;Note&quot;&gt;&lt;strong&gt;Note&lt;/strong&gt;: The U.S. Preventive Services Task Force (USPSTF) did not define a specific upper age limit for screening in women because the risk for fractures continues to increase with age and treatment harms remain no greater than small. Clinicians should take into account the patient\\\'s remaining lifespan when deciding whether to screen patients with significant illness."
25629	VA/DoD clinical practice guideline for the management of stroke rehabilitation	Adult patients (18 years or older) with post-stroke functional disability who may require rehabilitation in the Veterans Health Administration (VHA) or Department of Defense (DoD) healthcare system
25661	Recommendations from the EGAPP Working Group: genomic profiling to assess cardiovascular risk to improve cardiovascular health	"The general population of adults without known preexisting cardiovascular disease (CVD), regardless of family history"
25679	Liraglutide for the treatment of type 2 diabetes mellitus	Patients with type 2 diabetes mellitus
25709	"EFNS guidelines on the molecular diagnosis of channelopathies, epilepsies, migraine, stroke and dementias"	"Patients with suspected genetic disorders including channelopathies, epilepsies, migraine, stroke and dementias"
3185	Cardiac rehabilitation. A national clinical guideline	"Patients in Scotland in need of rehabilitation after myocardial infarction, coronary revascularization, angina, and heart failure"
32410	Exercise and type 2 diabetes: American College of Sports Medicine and the American Diabetes Association: joint position statement	"Patients with type 2 diabetes mellitus, gestational diabetes, prediabetes, and/or diabetes complications"
32417	"(1) Screening for delirium, dementia and depression in older adults. (2) Screening for delirium, dementia and depression in older adults 2010 supplement"	Older adults
32418	"(1) Caregiving strategies for older adults with delirium, dementia and depression. (2) Caregiving strategies for older adults with delirium, dementia and depression 2010 supplement"	"Older adults (65 years or older) with delirium, dementia and/or depression"
32419	(1) Nursing care of dyspnea: the 6th vital sign in individuals with chronic obstructive pulmonary disease (COPD). (2) Nursing care of dyspnea: the 6th vital sign in individuals with chronic obstructive pulmonary disease (COPD) 2010 supplement	&lt;ul type=&quot;disc&quot;&gt;\\r\\n&lt;li&gt;Patients with dyspnea associated with chronic obstructive pulmonary disease (COPD)&lt;/li&gt;\\r\\n&lt;li&gt;Adults with dyspnea who have a history of smoking and who are over the age of 40&lt;/li&gt;&lt;/ul&gt;
32422	American College of Rheumatology 2010 recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis	Adults who are or will be receiving glucocorticoids
32491	COPD management in the long-term care setting	Residents of long-term care facilities at risk for or with confirmed chronic obstructive pulmonary disease (COPD)
32492	Heart failure in the long-term care setting	Elderly residents of long-term care facilities
32493	Parkinson\'s disease in the long-term care setting	Residents of long-term care facilities with Parkinson\\\'s disease
32599	Dementia. Diagnosis and treatment	Patients with suspected or confirmed dementia
32645	ACR Appropriateness Criteria&amp;reg; cerebrovascular disease	Patients with cerebrovascular disease
32668	Depression in the long term care setting	Elderly residents of long-term care facilities at risk for or diagnosed with depression
32670	Stroke management in the long term care setting	Residents of long-term care facilities
33038	"Evidence-based guideline: treatment of painful diabetic neuropathy. Report of the American Academy of Neurology, the American Association of Neuromuscular and Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation"	Patients with painful diabetic neuropathy
33192	Acute coronary syndrome and myocardial infarction	People with ischemic chest pain suggesting unstable angina or myocardial infarction
33577	Espoguia (clinical guidelines for patients with spondyloarthritis)	Adults with spondyloarthritis (SpA) or suspected spondyloarthritis&lt;/p&gt;\\r\\n&lt;p class=&quot;Note&quot;&gt;&lt;strong&gt;Note&lt;/strong&gt;: This guideline will not refer to SpA in children.
34016	NIH Consensus Development Conference statement on preventing Alzheimer\'s disease and cognitive decline	United States population age 50 and older
34019	Wheelchair biking for the treatment of depression	Older adults in long-term care facilities who are depressed or at risk for depression
34053	General assessment. In: II guidelines for perioperative evaluation	Any patient who requires surgery
34055	Disease-specific approaches. In: II guidelines for perioperative evaluation	Patient who require surgery and who have any of the following diseases or conditions:&lt;/p&gt;\\r\\n&lt;ul style=&quot;list-style-type: disc;&quot;&gt;\\r\\n    &lt;li&gt;Coronary artery disease &lt;/li&gt;\\r\\n    &lt;li&gt;Hypertension &lt;/li&gt;\\r\\n    &lt;li&gt;Congestive heart failure &lt;/li&gt;\\r\\n    &lt;li&gt;Valvular heart disease &lt;/li&gt;\\r\\n    &lt;li&gt;Cardiac arrhythmias &lt;/li&gt;\\r\\n    &lt;li&gt;Conduction disorders &lt;/li&gt;\\r\\n    &lt;li&gt;Implanted pacemakers and implantable cardioverter-defibrillators &lt;/li&gt;\\r\\n    &lt;li&gt;Heart disease and the need for liver or kidney transplant &lt;/li&gt;\\r\\n    &lt;li&gt;Heart disease and pregnancy &lt;/li&gt;\\r\\n    &lt;li&gt;Heart disease and the need for dental procedures &lt;/li&gt;\\r\\n    &lt;li&gt;Aortic aneurysm &lt;/li&gt;\\r\\n&lt;/ul&gt;&lt;/div&gt;
34057	Steps to reduce surgical risk. In: II guidelines for perioperative evaluation	Any patient who requires surgery
34085	Public awareness of stroke. In: Canadian best practice recommendations for stroke care	All members of the public
34087	Prevention of stroke. In: Canadian best practice recommendations for stroke care	All persons at risk of stroke or who have had a stroke
34090	Acute stroke management. In: Canadian best practice recommendations for stroke care	All patients admitted to the hospital because of an acute stroke or transient ischemic attack
34091	Stroke rehabilitation. In: Canadian best practice recommendations for stroke care	All people with acute stroke who require rehabilitation
34092	Managing stroke care transitions. In: Canadian best practice recommendations for stroke care	"Adult and pediatric patients with stroke and their families and caregivers, at all stages across the continuum of stroke care"
34094	Cross-continuum topics in stroke management. In: Canadian best practice recommendations for stroke care	All patients with stroke
34113	Cardiometabolic risk management guidelines in primary care	"&lt;ul style=&quot;list-style-type: disc;&quot;&gt;\\r\\n    &lt;li&gt;Non-pregnant adult patients &lt;/li&gt;\\r\\n    &lt;li&gt;Individuals at increased risk for cardiovascular disease and type 2 diabetes mellitus, including:\\r\\n    &lt;ul style=&quot;list-style-type: disc;&quot;&gt;\\r\\n        &lt;li&gt;Individuals at age of 45 years and over (preferably, at age of 35 for male) &lt;/li&gt;\\r\\n        &lt;li&gt;All obese individuals &lt;/li&gt;\\r\\n        &lt;li&gt;All hypertensive, diabetic, and dyslipidemic individuals &lt;/li&gt;\\r\\n    &lt;/ul&gt;\\r\\n    &lt;/li&gt;\\r\\n&lt;/ul&gt;"
34166	Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus	Patients with diabetes mellitus
34168	Use of intensive insulin therapy for the management of glycemic control in hospitalized patients: a clinical practice guideline from the American College of Physicians	Adults with inpatient hyperglycemia in a hospital setting
34205	"Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory Society"	Adults with stable chronic obstructive pulmonary disease (COPD)
34265	Depression and mania in patients with HIV/AIDS	"Patients with human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS), including pregnant and postpartum women"
34271	Rapid response team	"All individuals within an acute care setting including inpatients, outpatients, volunteers, visitors, students, employees, etc."
34277	"Dietary guidelines for Americans, 2010"	"All Americans aged 2 years and older, including those at increased risk of chronic disease"
34278	Clopidogrel and modified-release dipyridamole for the prevention of occlusive vascular events	"People who have had an occlusive vascular event, or who have established peripheral arterial disease and people who have had myocardial infarction&lt;/p&gt;\\r\\n&lt;p class=&quot;Note&quot;&gt;&lt;strong&gt;Note&lt;/strong&gt;: This guidance does not apply to people who have had, or are at risk of, a stroke associated with atrial fibrillation, or who require treatment to prevent occlusive events after coronary revascularisation or carotid artery procedures."
34279	"Donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer\'s disease"	Patients with Alzheimer\\\'s disease (AD)
34281	Anaemia management in people with chronic kidney disease	"Adults and children with a clinical diagnosis of anaemia associated with chronic kidney disease (CKD), including:&lt;/p&gt;\\r\\n&lt;ul style=&quot;list-style-type: disc;&quot;&gt;\\r\\n    &lt;li&gt;Those with pre-dialysis CKD &lt;/li&gt;\\r\\n    &lt;li&gt;Those with established renal failure receiving renal replacement therapy &lt;/li&gt;\\r\\n    &lt;li&gt;Those with established renal failure receiving conservative management &lt;/li&gt;\\r\\n    &lt;li&gt;After renal transplant surgery &lt;/li&gt;\\r\\n&lt;/ul&gt;\\r\\n&lt;p class=&quot;Note&quot;&gt;&lt;strong&gt;Note&lt;/strong&gt;: Groups that are not covered include those for whom CKD is not the principal cause of the anaemia, for example anemia caused by:&lt;/p&gt;\\r\\n&lt;ul class=&quot;contentListFont&quot;&gt;\\r\\n    &lt;li&gt;Haematological disease &lt;/li&gt;\\r\\n    &lt;li&gt;Acute and chronic inflammatory disease states &lt;/li&gt;\\r\\n    &lt;li&gt;Malignancy &lt;/li&gt;\\r\\n    &lt;li&gt;Acquired immunodeficiency syndrome &lt;/li&gt;\\r\\n    &lt;li&gt;Acute kidney injury &lt;/li&gt;\\r\\n&lt;/ul&gt;&lt;/div&gt;"
34286	"Osteoporosis: diagnosis, treatment, and fracture prevention"	General adult population (age 19+ years)
34406	Depression	Adults with depressive disorders
34435	"Hand, wrist, and forearm disorders, not including carpal tunnel syndrome"	"Adults with potentially work-related hand, wrist, and forearm disorders seen in primary care settings"
34438	Care of the patient undergoing intracranial pressure monitoring/external ventricular drainage or lumbar drainage	Patients undergoing intracranial pressure (ICP) monitoring via an external ventricular drainage device (EVD) or subarachnoid drainage of cerebrospinal fluid with a lumbar drainage device (LDD)
34444	Clinical practice guideline for dementia. Part I: diagnosis &amp;amp; evaluation	South Koreans with known or suspected dementia or who are at risk of developing dementia
34447	Oral hygiene care for functionally dependent and cognitively impaired older adults	Older adults who are functionally dependent and cognitively impaired&lt;/p&gt;\\r\\n&lt;/div&gt;
34755	(1) Stroke assessment across the continuum of care. (2) Stroke assessment across the continuum of care 2011 supplement	Patients who have experienced or have risk factors for stroke
34756	(1) Prevention of falls and fall injuries in the older adult. (2) Prevention of falls and fall injuries in the older adult 2011 supplement	Older adults in healthcare settings at risk of falls and fall injuries
34758	Strategies to support self-management in chronic conditions: collaboration with clients	Adults in practice settings with chronic health conditions&lt;/p&gt;\\r\\n&lt;p class=&quot;Note&quot;&gt;&lt;strong&gt;Note&lt;/strong&gt;: Children have special assessment needs related to developmental stages that are beyond the scope of this guideline.
34765	Evidence based practice guidelines for the nutritional management of adults with pressure injuries	"Any adult who has one or more pre-existing pressure injury(ies)&lt;/p&gt;\\r\\n&lt;p class=&quot;Note&quot;&gt;&lt;strong&gt;Note&lt;/strong&gt;: By definition, those excluded are patients aged less than 16 years of age or who are under the care of a paediatric health care team. Other excluded groups are those for whom the dietary treatments outlined in the guidelines would cause harm due to another pre-existing medical condition, or where a practice guideline exists that would more closely meet their medical and nutritional requirements."
34772	"Guidelines for the prevention, detection and management of chronic heart failure in Australia"	"Patients with, or at risk of developing, chronic heart failure (CHF)"
34783	Atherosclerotic cardiovascular disease screening in adults: American College of Preventive Medicine position statement on preventive practice	Adults in the United States who are at risk for cardiovascular disease
34824	Hypertension. Clinical management of primary hypertension in adults	"&lt;ul style=&quot;list-style-type: disc;&quot;&gt;\\r\\n    &lt;li&gt;Adults with hypertension (18 years and older) with particular consideration given to the needs of black people of African and Caribbean family origin and minority ethnic groups where these differ from the needs of the general population. &lt;/li&gt;\\r\\n    &lt;li&gt;People aged 80 years or older &lt;/li&gt;\\r\\n&lt;/ul&gt;\\r\\n&lt;p class=&quot;Note&quot;&gt;&lt;strong&gt;Note&lt;/strong&gt;: Groups that are not covered include people with diabetes, children and young people (younger than 18 years), pregnant women, secondary causes of hypertension (for example, Conn\\\'s adenoma, phaeochromocytoma and renovascular hypertension), people with accelerated hypertension (that is, severe acute hypertension associated grade III retinopathy and encephalopathy), people with acute hypertension or high blood pressure in emergency care settings.&lt;/p&gt;"
34825	Management of stable angina	"Adults (18 years and older) who have been diagnosed with stable angina due to atherosclerotic disease, including:&lt;/p&gt;\\r\\n&lt;ul style=&quot;list-style-type: disc;&quot;&gt;\\r\\n    &lt;li&gt;People of south Asian origin &lt;/li&gt;\\r\\n    &lt;li&gt;People older than 85 years &lt;/li&gt;\\r\\n    &lt;li&gt;People with chronic refractory angina &lt;/li&gt;\\r\\n    &lt;li&gt;People with diabetes &lt;/li&gt;\\r\\n    &lt;li&gt;People with normal or minimally diseased coronary arteries &lt;/li&gt;\\r\\n    &lt;li&gt;Women &lt;/li&gt;\\r\\n&lt;/ul&gt;\\r\\n&lt;p class=&quot;Note&quot;&gt;&lt;strong&gt;Note&lt;/strong&gt;: Groups that are not covered in the guideline include people with recent-onset chest pain or discomfort of suspected cardiac origin, people with acute coronary syndrome, people with chest pain or discomfort of unknown cause, people with angina-type pain that is likely to be due to non-cardiac disease, such as anaemia, people with angina-type pain associated with other types of heart disease, such as valvular heart disease (for example, aortic stenosis) or cardiomyopathy (for example, hypertrophic cardiomyopathy)."
34826	Peritoneal dialysis. Peritoneal dialysis in the treatment of stage 5 chronic kidney disease	People with stage 5 chronic kidney disease (CKD) who need and want to receive dialysis
34827	Hip fracture. The management of hip fracture in adults	"&lt;ul style=&quot;list-style-type: disc;&quot;&gt;\\r\\n    &lt;li&gt;Adults aged 18 years and older presenting to the health service with a clinical diagnosis (firm or provisional) of fragility fracture of the hip &lt;/li&gt;\\r\\n    &lt;li&gt;People with the following types of hip fracture:\\r\\n    &lt;ul style=&quot;list-style-type: disc;&quot;&gt;\\r\\n        &lt;li&gt;Intracapsular (undisplaced and displaced) &lt;/li&gt;\\r\\n        &lt;li&gt;Extracapsular (trochanteric and subtrochanteric) &lt;/li&gt;\\r\\n    &lt;/ul&gt;\\r\\n    &lt;/li&gt;\\r\\n    &lt;li&gt;Those with comorbidity strongly predictive of outcome, and those without such comorbidity &lt;/li&gt;\\r\\n&lt;/ul&gt;\\r\\n&lt;p class=&quot;Note&quot;&gt;&lt;strong&gt;Note&lt;/strong&gt;: These guidelines are not intended for use in the following patients:&lt;/p&gt;\\r\\n&lt;ul class=&quot;contentListFont&quot;&gt;\\r\\n    &lt;li&gt;People younger than 18 years &lt;/li&gt;\\r\\n    &lt;li&gt;People with fractures caused by specific pathologies other than osteoporosis or osteopaenia &lt;/li&gt;\\r\\n&lt;/ul&gt;"
34828	Common mental health disorders. Identification and pathways to care	"Adults (18 years and older) with common mental health disorders, that is:&lt;/p&gt;\\r\\n&lt;ul style=&quot;list-style-type: disc;&quot;&gt;\\r\\n    &lt;li&gt;Depression (including subthreshold disorders) &lt;/li&gt;\\r\\n    &lt;li&gt;Anxiety disorders (including generalised anxiety disorder, panic disorder, social anxiety, obsessive compulsive disorder, and post-traumatic stress disorder) &lt;/li&gt;\\r\\n    &lt;li&gt;Comorbid presentations of anxiety and depression &lt;/li&gt;\\r\\n&lt;/ul&gt;\\r\\n&lt;p class=&quot;note&quot;&gt;&lt;strong&gt;Note&lt;/strong&gt;: The following groups will not be covered:&lt;/p&gt;\\r\\n&lt;ul class=&quot;contentListFont&quot;&gt;\\r\\n    &lt;li&gt;Adults with:\\r\\n    &lt;ul style=&quot;list-style-type: disc;&quot;&gt;\\r\\n        &lt;li&gt;Subthreshold mixed anxiety and depression &lt;/li&gt;\\r\\n        &lt;li&gt;Psychotic and related disorders (including schizophrenia and bipolar disorder) &lt;/li&gt;\\r\\n        &lt;li&gt;Those for whom drug and alcohol misuse are the primary problem &lt;/li&gt;\\r\\n        &lt;li&gt;Those for whom eating disorders are the primary problem &lt;/li&gt;\\r\\n        &lt;li&gt;Children and people younger than 18 years old &lt;/li&gt;\\r\\n    &lt;/ul&gt;\\r\\n    &lt;/li&gt;\\r\\n&lt;/ul&gt;&lt;/div&gt;"
34831	Diabetic foot problems. Inpatient management of diabetic foot problems	Adults (18 years and older) with or at a particular high risk (high risk as defined in National Institute for Health and Clinical Excellence [NICE] clinical guideline 10) of diabetic foot problems admitted to hospital&lt;/p&gt;\\r\\n&lt;p class=&quot;Note&quot;&gt;&lt;strong&gt;Note&lt;/strong&gt;: Children (younger than 18 years) will not be covered.
34837	Hyperglycaemia in acute coronary syndromes. Management of hyperglycaemia in acute coronary syndromes	"&lt;ul style=&quot;list-style-type: disc;&quot;&gt;\\r\\n    &lt;li&gt;Adults with acute coronary syndromes and hyperglycaemia with a diagnosis of diabetes &lt;/li&gt;\\r\\n    &lt;li&gt;Adults with acute coronary syndromes and hyperglycaemia without a diagnosis of diabetes &lt;/li&gt;\\r\\n    &lt;li&gt;Subgroups who are at higher risk of mortality and poorer outcomes associated with acute coronary syndrome, as appropriate &lt;/li&gt;\\r\\n&lt;/ul&gt;\\r\\n&lt;p class=&quot;Note&quot;&gt;&lt;strong&gt;Note&lt;/strong&gt;: Groups not covered:&lt;/p&gt;\\r\\n&lt;ul class=&quot;contentListFont&quot;&gt;\\r\\n    &lt;li&gt;Adults with hyperglycaemia who do not have acute coronary syndromes &lt;/li&gt;\\r\\n    &lt;li&gt;Adults with acute coronary syndromes who do not have hyperglycaemia &lt;/li&gt;\\r\\n&lt;/ul&gt;"
34900	Late (complicated) Parkinson\'s disease	Patients with late (complicated) Parkinson\\\'s disease (PD)
34910	Use of imaging in cerebrovascular disease	Patients with acute stroke
34950	Management of early rheumatoid arthritis. A national clinical guideline	Adults with rheumatoid arthritis
34968	American Association of Clinical Endocrinologists medical guidelines for clinical practice for the diagnosis and treatment of postmenopausal osteoporosis	Postmenopausal women
34978	Guidelines on oral anticoagulation with warfarin - fourth edition	People in the United Kingdom with conditions requiring anticoagulation prophylaxis or therapy
34979	2011 ACCF/AHA guideline for coronary artery bypass graft surgery: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines	Adults with coronary artery disease
34980	2011 ACCF/AHA/SCAI guideline for percutaneous coronary artery intervention. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions	Patients with coronary artery disease
34981	2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines	Adult and pediatric patients with hypertrophic cardiomyopathy
35129	(1) Guidelines for the management of acute coronary syndromes 2006. (2) 2007 addendum to the National Heart Foundation of Australia/Cardiac Society of Australia and New Zealand guidelines for the management of acute coronary syndromes 2006. (3) 2011 addendum to the National Heart Foundation of Australia/Cardiac Society of Australia and New Zealand guidelines for the management of acute coronary syndromes (ACS) 2006	"Patients with acute coronary syndromes (ACS), which includes a broad spectrum of clinical presentations, spanning ST-segment-elevation myocardial infarction, through to an accelerated pattern of angina without evidence of myonecrosis&lt;/p&gt;\\r\\n&lt;p&gt;&lt;strong&gt;2011 Addendum&lt;/strong&gt;&lt;/p&gt;\\r\\n&lt;p&gt;Patients with spontaneous ACS, rather than those occurring as a result of other conditions (e.g., anaemia or thyrotoxicosis) where management may be directed at the underlying cause"
35131	HealthPartners Dental Group and Clinics periodontal risk assessment guideline	HealthPartners Dental Group patients
35236	Osteoporosis: prevention and treatment	"Postmenopausal women and persons at risk for secondary osteoporosis related to long-term glucocorticoid use, organ transplant, or other medical conditions"
35239	Diabetes management at camps for children with diabetes	Children and adolescent campers with diabetes
35254	Continuous glucose monitoring: an Endocrine Society clinical practice guideline	Adult and pediatric patients with type 1 diabetes mellitus (T1DM) and type 2 diabetes mellitus (T2DM)
35255	Management of hyperglycemia in hospitalized patients in non-critical care setting: an Endocrine Society clinical practice guideline	Hospitalized patients in non-critical care settings who have diagnosed or suspected type 1 diabetes mellitus (T1DM) or type 2 diabetes mellitus (T2DM) or &quot;stress hyperglycemia&quot;
35257	Oral pharmacologic treatment of type 2 diabetes mellitus: a clinical practice guideline from the American College of Physicians	Adults with type 2 diabetes
35259	Practice guidelines for acute pain management in the perioperative setting. An updated report by the American Society of Anesthesiologists Task Force on Acute Pain Management	"Adult (including geriatric) and pediatric patients undergoing either inpatient or outpatient surgery&lt;/p&gt;\\r\\n&lt;p class=&quot;Note&quot;&gt;&lt;strong&gt;Note&lt;/strong&gt;: These guidelines do not apply to the following populations:&lt;/p&gt;\\r\\n&lt;ul class=&quot;contentListFont&quot;&gt;\\r\\n    &lt;li&gt;Patients with severe or concurrent medical illness such as sickle cell crisis, pancreatitis, or acute pain related to cancer or cancer treatment &lt;/li&gt;\\r\\n    &lt;li&gt;Patients with labor pain &lt;/li&gt;\\r\\n&lt;/ul&gt;&lt;/div&gt;"
35262	"Evidence-based management of anticoagulant therapy: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines"	"Patients requiring anticoagulant therapy&lt;/p&gt;\\r\\n&lt;p class=&quot;Note&quot;&gt;&lt;strong&gt;Note&lt;/strong&gt;: This guideline does not address anticoagulation management issues specific to pregnancy or to children. Issues believed to be specific to a particular diagnosis, such as venous thromboembolism (VTE) or atrial fibrillation, are dealt with in those specific articles of the original guideline supplement."
35269	"Treatment and prevention of heparin-induced thrombocytopenia: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines"	Patients receiving unfractionated or low-molecular-weight heparin considered at risk of heparin-induced thrombocytopenia (HIT) or in whom the exposure history of the patient is uncertain
35270	"Antithrombotic therapy for atrial fibrillation: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines"	"Patients with atrial fibrillation (AF)&lt;/p&gt;\\r\\n&lt;p class=&quot;Note&quot;&gt;&lt;strong&gt;Note&lt;/strong&gt;: This guideline does not give recommendations for antithrombotic therapy in patients with AF around the time of surgical or invasive procedures, at the time of presentation with acute stroke, or in patients with AF who have prosthetic heart valves. This guideline does not give recommendations for patients with AF who are pregnant. The recommendations in this guideline apply to patients with persistent and permanent AF and to patients with paroxysmal AF but do not apply to patients with a single, transient, self-limited episode of AF associated with acute illness."
35271	"Antithrombotic and thrombolytic therapy for valvular disease: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines"	Patients with valvular heart disease requiring treatment with antithrombotic therapy
35272	"Antithrombotic and thrombolytic therapy for ischemic stroke: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines"	"Patients with or at risk of acute ischemic stroke, transient ischemic attacks (TIA), intracerebral hemorrhage (ICH), and cerebral venous sinus thrombosis"
35273	"Primary and secondary prevention of cardiovascular disease: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines"	Patients at risk for cardiovascular disease (CVD)
35578	Family history of early atherosclerotic cardiovascular disease. In: Expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents	"Infants, children, and adolescents in the general population and their parents and families"
35922	Consultation and referral guidelines citing the evidence: how the allergist/immunologist can help	Adults and children with allergies or asthma
36195	The 2012 hormone therapy position statement of The North American Menopause Society	Perimenopausal and postmenopausal women
36628	Clinical practice guideline for type 2 diabetes	Patients in Spain seen in an outpatient setting who are at risk for or diagnosed with diabetes mellitus type 2
36825	Critical care management of patients following aneurysmal subarachnoid hemorrhage: recommendations from the Neurocritical Care Society\'s Multidisciplinary Consensus Conference	Patients with acute aneurysmal subarachnoid hemorrhage
36826	"Occupational asthma: prevention, identification &amp;amp; management: systematic review &amp;amp; recommendations"	Workers with or at risk of occupational asthma
36829	Update of the clinical practice guideline for the management of rheumatoid arthritis in Spain	Adult patients with rheumatoid arthritis living in Spain
36874	Appropriate chemotherapy dosing for obese adult patients with cancer: American Society of Clinical Oncology clinical practice guideline	Obese adult patients with cancer
36887	Dabigatran etexilate for the prevention of stroke and systemic embolism in atrial fibrillation	"Patients in England and Wales with atrial fibrillation and one or more of the following risk factors:&lt;/p&gt;\\r\\n&lt;ul style=&quot;list-style-type: disc;&quot;&gt;\\r\\n    &lt;li&gt;Previous stroke, transient ischaemic attack or systemic embolism &lt;/li&gt;\\r\\n    &lt;li&gt;Left ventricular ejection fraction below 40% &lt;/li&gt;\\r\\n    &lt;li&gt;Symptomatic heart failure of New York Heart Association (NYHA) class 2 or above &lt;/li&gt;\\r\\n    &lt;li&gt;Age 75 years or older &lt;/li&gt;\\r\\n    &lt;li&gt;Age 65 years or older with one of the following: diabetes mellitus, coronary artery disease or hypertension &lt;/li&gt;\\r\\n&lt;/ul&gt;&lt;/div&gt;"
36888	Exenatide prolonged-release suspension for injection in combination with oral antidiabetic therapy for the treatment of type 2 diabetes	Adults in England and Wales who have not achieved adequate glycaemic control on maximally tolerated doses of oral antidiabetic therapies
36890	Tocilizumab for the treatment of rheumatoid arthritis (rapid review of technology appraisal guidance 198)	"Patients in England and Wales with moderate to severe active rheumatoid arthritis whose rheumatoid arthritis has responded inadequately to one or more disease modifying anti-rheumatic drugs (DMARDs) or tumour necrosis factor alpha (TNF-&amp;alpha;) inhibitors and whose rheumatoid arthritis has responded inadequately to rituximab, or in whom rituximab is not tolerated or is contraindicated"
36892	2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis	Patients with rheumatoid arthritis
36893	"American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee"	"Patients with osteoarthritis of the hand, hip, and/or knee"
36895	Evidence-based guideline: intravenous immunoglobulin in the treatment of neuromuscular disorders. Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology	Patients with neuromuscular disorders
36906	Prevention of falls (acute care). Health care protocol	Adult hospitalized patients in the acute care setting
37220	2012 Infectious Diseases Society of America clinical practice guideline for the diagnosis and treatment of diabetic foot infections	Diabetic patients with a foot wound
37286	British Thoracic Society guideline for advanced diagnostic and therapeutic flexible bronchoscopy in adults	"Adults with central airway obstruction due to malignancy, emphysema, asthma, and lung cancer who may undergo flexible bronchoscopy for diagnosis or treatment&lt;/p&gt;\\r\\n&lt;p class=&quot;Note&quot;&gt;&lt;strong&gt;Note&lt;/strong&gt;: Rigid bronchoscopy and autofluorescence bronchoscopy are not covered in this guideline."
37288	Guidelines for the prevention and management of &lt;em&gt;Mycobacterium tuberculosis&lt;/em&gt; infection and disease in adult patients with chronic kidney disease	&lt;ul style=&quot;list-style-type: disc;&quot;&gt;\\r\\n    &lt;li&gt;Patients with all stages of chronic kidney disease (CKD) &lt;/li&gt;\\r\\n    &lt;li&gt;Patients on peritoneal dialysis and haemodialysis &lt;/li&gt;\\r\\n    &lt;li&gt;Patients with renal transplants &lt;/li&gt;\\r\\n    &lt;li&gt;Patients with latent tuberculosis (TB) infection &lt;/li&gt;\\r\\n&lt;/ul&gt;
37691	Allergen immunotherapy: a practice parameter third update	&lt;ul style=&quot;list-style-type: disc;&quot;&gt;\\r\\n    &lt;li&gt;Patients with allergic diseases whose symptoms are not controlled adequately by medications and avoidance measures or those experiencing unacceptable adverse effects of medications or who wish to reduce the long-term use of medications &lt;/li&gt;\\r\\n    &lt;li&gt;Patients with a history of a systemic reaction to Hymenoptera stings who demonstrate Hymenoptera-specific immunoglobulin E (IgE) antibodies &lt;/li&gt;\\r\\n&lt;/ul&gt;
37693	American Association of Clinical Endocrinologists\' guidelines for management of dyslipidemia and prevention of atherosclerosis	"Children older than 2 years old, adolescents, and adults with or at risk for dyslipidemia or atherosclerosis"
37694	Assessing heart failure in long term care facilities	"&lt;ul style=&quot;list-style-type: disc;&quot;&gt;\\r\\n    &lt;li&gt;Geriatric patients in long-term care settings with classification I, II, III, or IV heart failure according to the New York Heart Association (NYHA) criteria (see appendix E in the original guideline document) &lt;/li&gt;\\r\\n    &lt;li&gt;Geriatric patients who have known risk factors for HF should be evaluated using a systematic approach as described in this clinical practice guideline. Risk factors include chronic conditions such as:\\r\\n    &lt;ul style=&quot;list-style-type: disc;&quot;&gt;\\r\\n        &lt;li&gt;coronary artery disease &lt;/li&gt;\\r\\n        &lt;li&gt;diabetes, hypertension &lt;/li&gt;\\r\\n        &lt;li&gt;myocardial ischemia &lt;/li&gt;\\r\\n        &lt;li&gt;previous diagnosis of heart failure &lt;/li&gt;\\r\\n        &lt;li&gt;myocardial infarction &lt;/li&gt;\\r\\n        &lt;li&gt;left ventricular dysfunction &lt;/li&gt;\\r\\n        &lt;li&gt;cardiomyopathy &lt;/li&gt;\\r\\n    &lt;/ul&gt;\\r\\n    &lt;/li&gt;\\r\\n&lt;/ul&gt;"
37707	AGS/BGS clinical practice guideline: prevention of falls in older persons	&lt;ul style=&quot;list-style-type: disc;&quot;&gt;\\r\\n    &lt;li&gt;Community-residing older persons (&amp;gt;65 years) &lt;/li&gt;\\r\\n    &lt;li&gt;Older persons in long-term care facilities &lt;/li&gt;\\r\\n    &lt;li&gt;Older persons with cognitive impairment &lt;/li&gt;\\r\\n&lt;/ul&gt;
37710	Screening for and management of obesity in adults: U.S. Preventive Services Task Force recommendation statement	Adults aged 18 years or older
37711	Behavioral counseling interventions to promote a healthful diet and physical activity for cardiovascular disease prevention in adults: U.S. Preventive Services Task Force recommendation statement	"General adult population without a known diagnosis of hypertension, diabetes, hyperlipidemia, or cardiovascular disease (CVD)"
37780	"Pathogenesis, prevalence, diagnosis, and management of exercise-induced bronchoconstriction: a practice parameter"	"Patients having or suspected of having exercise-induced bronchoconstriction (EIB), with or without chronic asthma, including recreational and elite athletes and nonathletes"
37827	Osteoporosis in men: an Endocrine Society clinical practice guideline	"Men at risk of osteoporosis:&lt;/p&gt;\\r\\n&lt;ul style=&quot;list-style-type: disc;&quot;&gt;\\r\\n    &lt;li&gt;Higher risk men (aged &amp;ge;70) &lt;/li&gt;\\r\\n    &lt;li&gt;Men aged 50&amp;ndash;69 who have risk factors (e.g., low body weight, prior fracture as an adult, smoking, etc.) &lt;/li&gt;\\r\\n&lt;/ul&gt;&lt;/div&gt;"
37915	ACR Appropriateness Criteria&amp;reg; suspected osteomyelitis of the foot in patients with diabetes mellitus	Patients with diabetes mellitus who are suspected to have osteomyelitis of the foot
37941	ACR Appropriateness Criteria&amp;reg; renovascular hypertension	Patients with a high or a low index of suspicion of renovascular hypertension (&quot;essential&quot; hypertension) and a normal or diminished renal function
38244	KDIGO clinical practice guideline for glomerulonephritis	Adults and children already diagnosed with glomerulonephritis (GN)
38245	KDIGO clinical practice guideline for anemia in chronic kidney disease	Patients (adult and children) with chronic kidney disease at risk for or with anemia
38250	Screening for coronary heart disease with electrocardiography: U.S. Preventive Services Task Force recommendation statement	Adult men and women without symptoms of heart disease or a diagnosis of cardiovascular disease
38254	Diagnosis and initial treatment of ischemic stroke	Patients age 18 years or older with symptoms of ischemic stroke or transient ischemic attack
38255	Diagnosis and management of asthma	Patients over 5 years of age who present with asthma-like symptoms or have been diagnosed with asthma
38360	Ottawa Panel evidence-based clinical practice guidelines for the management of osteoarthritis in adults who are obese or overweight	Adults (&amp;gt;18 years of age) with osteoarthritis (OA) who are obese or overweight (body mass index &amp;ge;25 kg/m&lt;sup&gt;2&lt;/sup&gt;)
38365	Screening for chronic kidney disease: U.S. Preventive Services Task Force recommendation statement&lt;/div&gt;	Asymptomatic adults without diagnosed chronic kidney disease (CKD)&lt;/p&gt;\\r\\n&lt;p class=&quot;Note&quot;&gt;&lt;strong&gt;Note&lt;/strong&gt;: This recommendation does &lt;em&gt;not&lt;/em&gt; apply to patients undergoing testing for and monitoring CKD for the purpose of chronic disease management (including testing and monitoring patients with diabetes or hypertension)
38367	Antithrombotics: indications and management. A national clinical guideline	Adult patients on antithrombotic therapy
38410	Osteoporosis: assessing the risk of fragility fracture	"&lt;ul style=&quot;list-style-type: disc;&quot;&gt;\\r\\n    &lt;li&gt;All women aged 65 years and over and all men aged 75 years and over &lt;/li&gt;\\r\\n    &lt;li&gt;Women aged under 65 years and men aged under 75 years in the presence of risk factors, for example:\\r\\n    &lt;ul style=&quot;list-style-type: disc;&quot;&gt;\\r\\n        &lt;li&gt;Previous fragility fracture &lt;/li&gt;\\r\\n        &lt;li&gt;Current use or frequent recent use of oral or systemic glucocorticoids &lt;/li&gt;\\r\\n        &lt;li&gt;History of falls &lt;/li&gt;\\r\\n        &lt;li&gt;Family history of hip fracture &lt;/li&gt;\\r\\n        &lt;li&gt;Other causes of secondary osteoporosis &lt;/li&gt;\\r\\n        &lt;li&gt;Low body mass index (BMI) (less than 18.5 kg/m&lt;sup&gt;2&lt;/sup&gt;) &lt;/li&gt;\\r\\n        &lt;li&gt;Smoking &lt;/li&gt;\\r\\n        &lt;li&gt;Alcohol intake of more than 14 units per week for women and more than 21 units per week for men &lt;/li&gt;\\r\\n    &lt;/ul&gt;\\r\\n    &lt;/li&gt;\\r\\n    &lt;li&gt;Women and men under 50 years of age who have major risk factors (for example, current or frequent recent use of oral or systemic glucocorticoids, untreated premature menopause or previous fragility fracture) &lt;/li&gt;\\r\\n&lt;/ul&gt;"
38413	Osteoporosis	"&lt;ul style=&quot;list-style-type: disc;&quot;&gt;\\r\\n    &lt;li&gt;Adolescent and adult women (&lt;em&gt;counseling&lt;/em&gt;) &lt;/li&gt;\\r\\n    &lt;li&gt;Women 65 years of age or older (&lt;em&gt;screening&lt;/em&gt;) &lt;/li&gt;\\r\\n    &lt;li&gt;Postmenopausal women with or at risk of developing osteoporosis (&lt;em&gt;screening, prevention, treatment&lt;/em&gt;) &lt;/li&gt;\\r\\n&lt;/ul&gt;"
38432	Evaluation and treatment of hypertriglyceridemia: an Endocrine Society clinical practice guideline	Adults
38443	Alteplase for treating acute ischaemic stroke (review of technology appraisal guidance 122)	Adult patients with acute ischaemic stroke within 4.5 hours of symptom onset
38460	Basic guidelines for diabetes care	"Adults, children, and adolescents with type 1 and type 2 diabetes mellitus"
38470	EFNS-ENS guidelines on the diagnosis and management of disorders associated with dementia	Patients with suspected or diagnosed dementia other than Alzheimer\\\'s disease
38471	EFNS guidelines for the diagnosis and management of Alzheimer\'s disease	Patients with suspected or diagnosed Alzheimer\\\'s disease
38473	Recommendations on screening for type 2 diabetes in adults	"Asymptomatic adults (18 years of age or older) at low-to-moderate, high, or very high risk of type 2 diabetes&lt;/p&gt;\\r\\n&lt;p class=&quot;Note&quot;&gt;&lt;strong&gt;Note&lt;/strong&gt;: The guideline does not apply to people with symptoms of diabetes or those who are at risk of type 1 diabetes."
38490	A.S.P.E.N. clinical guidelines: nutrition support of adult patients with hyperglycemia	Adult hospitalized patients receiving nutrition support
38528	Occupational therapy practice guidelines for adults with serious mental illness	Adults (aged 18 to 65 years) with serious mental illness
38537	Menopausal hormone therapy for the primary prevention of chronic conditions: U.S. Preventive Services Task Force recommendation statement	"Postmenopausal women who are considering hormone therapy for the primary prevention of chronic medical conditions&lt;/p&gt;\\r\\n&lt;p class=&quot;Note&quot;&gt;&lt;strong&gt;Note&lt;/strong&gt;: These recommendations do not apply to women who are considering hormone therapy for the management of menopausal symptoms, such as hot flashes or vaginal dryness, or women younger than 50 years who have had surgical menopause."
38618	Management of type 2 diabetes mellitus	Adults seen in primary care settings including those at risk for or diagnosed with diabetes mellitus
38655	BSR and BHPR guidelines on the use of rituximab in rheumatoid arthritis	Patients with rheumatoid arthritis
38656	BSR and BHPR rheumatoid arthritis guidelines on safety of anti-TNF therapies	Adult patients in the United Kingdom with rheumatoid arthritis
38684	A.S.P.E.N. clinical guidelines: nutrition support in adult acute and chronic renal failure	Adults with acute or chronic renal failure
38688	Management of uncomplicated acute bronchitis in adults	Adults 18 years or older with clinical suspicion of uncomplicated acute bronchitis
38693	General principles for the diagnosis and management of asthma	"Children and adults with the following:&lt;/p&gt;\\r\\n&lt;ul style=&quot;list-style-type: disc;&quot;&gt;\\r\\n    &lt;li&gt;Wheezing &lt;/li&gt;\\r\\n    &lt;li&gt;History of cough (worse particularly at night), recurrent wheeze, recurrent difficulty in breathing, recurrent chest tightness &lt;/li&gt;\\r\\n    &lt;li&gt;Symptoms occur or worsen in the presence of exercise, viral infection, inhalant allergens, irritants, changes in weather, strong emotional expression (laughing or crying hard), stress, menstrual cycles &lt;/li&gt;\\r\\n    &lt;li&gt;Symptoms occur or worsen at night, awakening the patient&lt;/li&gt;\\r\\n&lt;/ul&gt;&lt;/div&gt;"
38697	Recommendations for optimal warfarin management for prevention of thromboembolic events in patients with atrial fibrillation	Patients with non-valvular atrial fibrillation requiring warfarin therapy
38885	Palliative care for the patient with incurable cancer or advanced disease. Part 2: pain and symptom management	"Adult patients &amp;ge;19 years of age with incurable or advanced cancer who experience pain, dyspnea, nausea and vomiting, constipation, delirium, fatigue and weakness, or depression"
38897	Chronic obstructive pulmonary disease (COPD)	Adults with chronic bronchitis or emphysema (chronic obstructive pulmonary disease [COPD])
38898	Diabetes care	Non-pregnant adults with or&amp;nbsp;at risk of developing type 1 and 2 diabetes mellitus (DM)
38928	"Australian guideline for prevention, diagnosis and management of acute rheumatic fever and rheumatic heart disease (2nd edition)"	Patients with or at risk of developing acute rheumatic fever or rheumatic heart disease
39220	Ivabradine for treating chronic heart failure	"People with chronic heart failure New York Heart Association (NYHA) class II to IV with systolic dysfunction, in sinus rhythm and whose heart rate is 75 beats per minute (bpm) or more, who are being treated with ivabradine in combination with standard therapy including beta-blockers, or for whom beta-blockers are contraindicated or not tolerated"
39222	2012 EHRA/HRS expert consensus statement on cardiac resynchronization therapy in heart failure: implant and follow-up recommendations and management	Patients with symptomatic heart failure who are considered for cardiac resynchronization therapy (CRT)
39242	Genetic counseling and testing for Alzheimer disease: joint practice guidelines of the American College of Medical Genetics and the National Society of Genetic Counselors	Individuals who may benefit from genetic counseling and testing for Alzheimer disease
39244	"Rheumatoid arthritis: diagnosis, management and monitoring"	Patients 16 years of age and older with early or established rheumatoid arthritis (RA)
39247	"2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design"	Patients with atrial fibrillation who are candidates for catheter or surgical ablation
39253	Diagnosis of stable ischemic heart disease: summary of a clinical practice guideline from the American College of Physicians/American College of Cardiology Foundation/American Heart Association/American Association for Thoracic Surgery/Preventive Cardiovascular Nurses Association/Society of Thoracic Surgeons	All adult patients with stable known or suspected ischemic heart disease
39320	Diagnosis and treatment of chest pain and acute coronary syndrome (ACS)	Adults presenting with past or present symptoms of chest pain/discomfort and/or indications of acute coronary syndromes
39338	Screening for cardiovascular disease and risk factors	Individuals in Singapore who are asymptomatic but who may be at risk for cardiovascular disease
39343	Functional screening for older adults in the community	Older community-dwelling adults living in Singapore
39352	ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012	Adults with acute or chronic heart failure
39354	European guidelines on cardiovascular disease prevention in clinical practice (version 2012)	&lt;ul style=&quot;list-style-type: disc;&quot;&gt;\\r\\n    &lt;li&gt;European patients with established cardiovascular disease (CVD) &lt;/li&gt;\\r\\n    &lt;li&gt;Asymptomatic individuals in Europe who are at increased risk of CVD mortality &lt;/li&gt;\\r\\n    &lt;li&gt;First-degree relatives of Europeans with premature CVD &lt;/li&gt;\\r\\n    &lt;li&gt;Other individuals encountered in routine clinical practice &lt;/li&gt;\\r\\n&lt;/ul&gt;
39379	ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation	Patients with suspected acute coronary syndromes without persistent ST-segment elevation
39380	2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS guideline for the diagnosis and management of patients with stable ischemic heart disease	"&lt;ul style=&quot;list-style-type: disc;&quot;&gt;\\r\\n    &lt;li&gt;Adult patients with stable known or suspected ischemic heart disease (IHD), including new-onset chest pain (i.e., low-risk unstable angina [UA]) &lt;/li&gt;\\r\\n    &lt;li&gt;Adult patients with stable pain syndromes, including patients who have &quot;ischemic equivalents,&quot; such as dyspnea or arm pain with exertion &lt;/li&gt;\\r\\n    &lt;li&gt;Asymptomatic patients who were previously symptomatic, including those who have undergone percutaneous coronary intervention (PCI) or coronary artery bypass graft (CABG) &lt;/li&gt;\\r\\n    &lt;li&gt;Asymptomatic patients with stable ischemic heart disease (SIHD) that has been diagnosed solely on the basis of an abnormal screening study &lt;/li&gt;\\r\\n&lt;/ul&gt;\\r\\n&lt;p class=&quot;Note&quot;&gt;&lt;strong&gt;Note&lt;/strong&gt;: The following populations are beyond the scope of this guideline:&lt;/p&gt;\\r\\n&lt;ul class=&quot;contentListFont&quot;&gt;\\r\\n    &lt;li&gt;Patients with acute myocardial infarction (AMI) or moderate- to high-risk UA &lt;/li&gt;\\r\\n    &lt;li&gt;Patients with IHD who develop recurrent chest pain if evaluation demonstrates that IHD is unlikely to cause the symptoms (i.e., noncardiac causes) &lt;/li&gt;\\r\\n    &lt;li&gt;Asymptomatic patients who are at risk for IHD but who are not known to have IHD &lt;/li&gt;\\r\\n    &lt;li&gt;Patients with chest pain symptoms early after revascularization by either percutaneous techniques or CABG (i.e., within 6 months of revascularization) &lt;/li&gt;\\r\\n    &lt;li&gt;Patients with chest pain syndromes after cardiac transplantation &lt;/li&gt;\\r\\n    &lt;li&gt;Pediatric patients &lt;/li&gt;\\r\\n&lt;/ul&gt;"
39382	Taiwan osteoporosis practice guidelines	Adults at risk for or diagnosed with osteoporosis
39393	Kidney disease in HIV-infected patients	Human immunodeficiency virus (HIV)-infected patients at risk of or diagnosed with kidney disease
39404	Critical illness evidence-based nutrition practice guideline	Adult critically-ill patients 19 years and older requiring or eligible for enteral nutrition support in the intensive care unit (ICU)&lt;/p&gt;\\r\\n&lt;p class=&quot;Note&quot;&gt;&lt;strong&gt;Note&lt;/strong&gt;: The evidence for the guideline did not specifically examine populations that were exclusively patients with burns. These guidelines are not applicable to pediatric populations.
39405	Food and nutrition for older adults promoting health and wellness (FNOA)	Older adults (aged 60 years and older)
39429	2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines	&lt;ul style=&quot;list-style-type: disc;&quot;&gt;\\r\\n    &lt;li&gt;Adults with ST-elevation myocardial infarction (STEMI) &lt;/li&gt;\\r\\n    &lt;li&gt;Adults at risk of STEMI &lt;/li&gt;\\r\\n&lt;/ul&gt;
39430	KDIGO clinical practice guideline for the management of blood pressure in chronic kidney disease	&lt;ul style=&quot;list-style-type: disc;&quot;&gt;\\r\\n    &lt;li&gt;Adults with non-dialysis-dependent chronic kidney disease (CKD ND) without diabetes mellitus &lt;/li&gt;\\r\\n    &lt;li&gt;Adults with CKD ND with diabetes mellitus &lt;/li&gt;\\r\\n    &lt;li&gt;Adults with CKD ND who have received a kidney transplant (CKD T) &lt;/li&gt;\\r\\n    &lt;li&gt;Children with CKD ND &lt;/li&gt;\\r\\n    &lt;li&gt;Elderly with CKD ND &lt;/li&gt;\\r\\n&lt;/ul&gt;
39432	Diagnosis and treatment of depression in adults: 2012 clinical practice guideline	Adults with mild to moderate major depressive disorder
39435	World Alzheimer report 2011: the benefits of early diagnosis and intervention	Persons aged 65 years and over with complaints of memory impairment
39539	Management of newly diagnosed type 2 diabetes mellitus (T2DM) in children and adolescents	Patients 10 years to less than 18 years of age with type 2 diabetes mellitus (T2DM)
43788	KDOQI clinical practice guideline for diabetes and CKD: 2012 update&lt;/div&gt;	"Patients with diabetes mellitus with or without chronic kidney disease (CKD) stages 1 to 5, including dialysis and transplant patients"
43837	Apixaban for preventing stroke and systemic embolism in people with nonvalvular atrial fibrillation	"Adult patients with nonvalvular atrial fibrillation, with 1 or more risk factors, such as prior stroke or transient ischaemic attack, age 75 years or older, hypertension, diabetes mellitus, or symptomatic heart failure (New York Heart Association [NYHA] class 2 or higher)"
43850	"Preventive activities in middle age. In: Guidelines for preventive activities in general practice, 8th edition"	"Low-risk individuals aged 45 to 64 years (i.e., middle-aged) living in Australia, including Aboriginal and Torres Strait Islander people"
43851	"Preventive activities in older age. In: Guidelines for preventive activities in general practice, 8th edition"	"Individuals aged &amp;ge;65 in the Australian population, including Aboriginal and Torres Strait Islander peoples"
43853	"Prevention of chronic disease. In: Guidelines for preventive activities in general practice, 8th edition"	"General population living in Australia, including the Aboriginal and Torres Strait Islander population&lt;/p&gt;\\r\\n&lt;ul style=&quot;list-style-type: disc;&quot;&gt;\\r\\n    &lt;li&gt;Smoking: individuals &amp;ge;10 years &lt;/li&gt;\\r\\n    &lt;li&gt;Overweight, nutrition, physical activity: all individuals &lt;/li&gt;\\r\\n    &lt;li&gt;Early detection of problem drinking: individuals &amp;ge;15 years &lt;/li&gt;\\r\\n&lt;/ul&gt;&lt;/div&gt;"
43854	"Prevention of vascular and metabolic disease. In: Guidelines for preventive activities in general practice, 8th edition"	Adult Australian population&lt;/p&gt;\\r\\n&lt;p class=&quot;Note&quot;&gt;&lt;strong&gt;Note&lt;/strong&gt;: See the &quot;Major Recommendations&quot; field for age ranges associated with specific conditions.
43860	"Osteoporosis. In: Guidelines for preventive activities in general practice, 8th edition"	&lt;ul style=&quot;list-style-type: disc;&quot;&gt;\\r\\n    &lt;li&gt;Australian women aged &amp;ge;45 years &lt;/li&gt;\\r\\n    &lt;li&gt;Australian men aged &amp;ge;50 years &lt;/li&gt;\\r\\n&lt;/ul&gt;
43863	Clinical practice guidelines: depression in adolescents and young adults	"Adolescents and young adults aged 13 to 24 years living in Australia&lt;/p&gt;\\r\\n&lt;p class=&quot;Note&quot;&gt;&lt;strong&gt;Note&lt;/strong&gt;: The following are not included in the guidelines:&lt;/p&gt;\\r\\n&lt;ul class=&quot;contentListFont&quot;&gt;\\r\\n    &lt;li&gt;First episode psychosis &lt;/li&gt;\\r\\n    &lt;li&gt;The specific management of patients with other physical or non-mood psychiatric conditions (co-occurring conditions) &lt;/li&gt;\\r\\n    &lt;li&gt;Depressive disorders with no published outcomes in the specified age range &lt;/li&gt;\\r\\n&lt;/ul&gt;\\r\\n&lt;p class=&quot;Note&quot;&gt;The diagnosis and pharmacological treatment of paediatric bipolar disorder is outside the age scope of these guidelines. Paediatric bipolar disorder is mentioned where appropriate, however, discussion should not be seen as validation of a condition that the Expert Working Committee considers to be very rare."
43906	EFNS task force: the use of neuroimaging in the diagnosis of dementia	Patients with suspected or diagnosed Alzheimer\\\'s disease (AD) or dementia
43916	Age-related changes in health. In: Evidence-based geriatric nursing protocols for best practice	Older adults
43917	Assessing cognitive functioning. In: Evidence-based geriatric nursing protocols for best practice	Hospitalized older adults
43921	Recognition and management of dementia. In: Evidence-based geriatric nursing protocols for best practice	Older patients with dementia
43922	Depression in older adults. In: Evidence-based geriatric nursing protocols for best practice	Hospitalized older adults
43926	"Heart failure: early recognition, and treatment of the patient at risk for hospital readmission. In: Evidence-based geriatric nursing protocols for best practice"	Adults aged 65 years and older
43940	Transitional care. In: Evidence-based geriatric nursing protocols for best practice	"Adults age 65 and older across health care settings (hospitals, nursing homes, assisted living, homecare)"
43946	Management of patients with refractory angina: Canadian Cardiovascular Society/Canadian Pain Society joint guidelines	Patients with refractory angina (RFA)
43955	Clinical Pharmacogenetics Implementation Consortium guidelines for thiopurine methyltransferase genotype and thiopurine dosing	Adults and children with conditions requiring thiopurine therapy
44088	Hyperphosphataemia in chronic kidney disease. Management of hyperphosphataemia in patients with stage 4 or 5 chronic kidney disease	"&lt;ul style=&quot;list-style-type: disc;&quot;&gt;\\r\\n    &lt;li&gt;Adults, children and young people with stage 4 or 5 chronic kidney disease who are not on dialysis and who are at risk of hyperphosphataemia &lt;/li&gt;\\r\\n    &lt;li&gt;Adults, children and young people with stage 5 chronic kidney disease who are receiving haemodialysis or peritoneal dialysis and are at risk of hyperphosphataemia &lt;/li&gt;\\r\\n&lt;/ul&gt;"
44323	Os odontoideum. In: Guidelines for the management of acute cervical spine and spinal cord injuries	"All patients with os odontoideum, including:&lt;/p&gt;\\r\\n&lt;ul style=&quot;list-style-type: disc;&quot;&gt;\\r\\n    &lt;li&gt;Patients with occipital-cervical pain alone &lt;/li&gt;\\r\\n    &lt;li&gt;Patients with myelopathy &lt;/li&gt;\\r\\n    &lt;li&gt;Patients with intracranial symptoms or signs from vertebrobasilar ischemia &lt;/li&gt;\\r\\n&lt;/ul&gt;&lt;/div&gt;"
44345	Diagnosis and management of chronic obstructive pulmonary disease (COPD)	Patients with symptoms of stable chronic obstructive pulmonary disease (COPD) as well as acute exacerbations of COPD in the outpatient setting
44350	Best evidence statement (BESt). Vital sign monitoring in children and adolescents who are overweight or obese in the outpatient physical therapy clinic	Children and adolescent patients ages 5 to 18 years with body mass index (BMI) &amp;gt;85&lt;sup&gt;th&lt;/sup&gt; percentile in the outpatient physical therapy setting
44984	Bathing persons with dementia	"Patients with Alzheimer\\\'s disease or non-Alzheimer\\\'s dementia who require bathing assistance, especially in the setting of long-term care facilities"
45001	Monitoring of nonsteroidal immunosuppressive drugs in patients with lung disease and lung transplant recipients: American College of Chest Physicians evidence-based clinical practice guidelines	&lt;ul style=&quot;list-style-type: disc;&quot;&gt;\\r\\n    &lt;li&gt;Patients with diffuse interstitial or inflammatory lung disease &lt;/li&gt;\\r\\n    &lt;li&gt;Lung transplant recipients &lt;/li&gt;\\r\\n&lt;/ul&gt;
45126	Abatacept for treating rheumatoid arthritis after the failure of conventional disease-modifying anti-rheumatic drugs (rapid review of technology appraisal guidance 234)	People with rheumatoid arthritis who have failed conventional disease-modifying anti-rheumatic drugs (DMARDs)
45128	Omalizumab for treating severe persistent allergic asthma (review of technology appraisal guidance 133 and 201)	Adults and adolescents aged at least 12 years and children aged six to 12 years with severe persistent allergic asthma
45130	Percutaneous vertebroplasty and percutaneous balloon kyphoplasty for treating osteoporotic vertebral compression fractures	People with osteoporotic vertebral compression fractures
45138	Recommendations for antithrombotic agents for the prevention of stroke and systemic embolism in patients with atrial fibrillation	Patients with non-valvular atrial fibrillation requiring anticoagulation
45378	Guideline for the laboratory diagnosis of functional iron deficiency	"Adult patients with chronic kidney disease (CKD) or other disease states in which erythropoiesis-stimulating agents (ESAs) have been used&lt;/p&gt;\\r\\n&lt;p class=&quot;Note&quot;&gt;&lt;strong&gt;Note&lt;/strong&gt;: The guidance may not be appropriate to patients with inflammatory diseases and in all cases individual patient circumstances may dictate an alternative approach. This guideline is only applicable to adults, not children."
45523	Health maintenance in the long term care setting	Residents of long term care (LTC) facilities (primarily the frail elderly)
45525	Dementia in the long term care setting	"Elderly individuals and/or residents of long term care (LTC) facilities who have, or are suspected of having, dementia"
45527	Diabetes management in the long term care setting	Elderly residents of long-term care (LTC) facilities with known or suspected diabetes
45688	Recommendations on screening for depression in adults	"Asymptomatic adults (18 years of age or older)&lt;/p&gt;\\r\\n&lt;p class=&quot;Note&quot;&gt;&lt;strong&gt;Note&lt;/strong&gt;: These recommendations do not apply to people with known depression, with a history of depression or who are receiving treatment for depression."
46239	Healthy lifestyles	"All adults age 18 and older in the community, irrespective of their utilization of the health care system&lt;/p&gt;\\r\\n&lt;p class=&quot;Note&quot;&gt;&lt;strong&gt;Note&lt;/strong&gt;: While many of the interventions and concepts presented in this guideline are effective in adolescents and children, the evidence for long-term benefits in children is not yet fully developed. Therefore, the work group members recommended that, for now, the scope of this guideline be limited to adults."
46240	Prevention and management of obesity for adults	Adult patients 18 years of age and older&lt;/p&gt;\\r\\n&lt;p class=&quot;Note&quot;&gt;&lt;strong&gt;Note&lt;/strong&gt;: This guideline does not address pregnant women or bodybuilders/weight trainers.
46241	Stable coronary artery disease	"Adults age 18 years or older who have a diagnosis of stable coronary artery disease. The criteria includes patients presenting with:&lt;/p&gt;\\r\\n&lt;ul style=&quot;list-style-type: disc;&quot;&gt;\\r\\n    &lt;li&gt;Previously diagnosed coronary artery disease without angina, or symptom complex that has remained stable for at least 60 days &lt;/li&gt;\\r\\n    &lt;li&gt;No change in frequency, duration, precipitating causes or ease of relief of angina for at least 60 days &lt;/li&gt;\\r\\n    &lt;li&gt;No evidence of recent myocardial damage &lt;/li&gt;\\r\\n&lt;/ul&gt;&lt;/div&gt;"
46413	2012 ACCF/AHA/HRS focused update incorporated into the ACCF/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society	"Children, adolescents, and adults in need of permanent cardiac pacemaker and/or implantable cardioverter-defibrillator (ICD) insertion to restore normal cardiac rhythm or prevent life-threatening cardiac arrhythmias"
46422	"American Academy of Orthopaedic Surgeons clinical practice guideline on the treatment of osteoarthritis of the knee, 2nd edition"	"Adults (ages 19 years and older) who have been diagnosed by a physician with osteoarthritis of the knee and are undergoing treatment&lt;/p&gt;\\r\\n&lt;p class=&quot;Note&quot;&gt;&lt;strong&gt;Note&lt;/strong&gt;: This guideline does not address patients diagnosed with rheumatoid arthritis, osteoarthritis of other joints, or other inflammatory arthropathies."
46459	Best evidence statement (BESt). Support from bedside nurses for caregivers of children newly diagnosed with type 1 diabetes mellitus	"Caregivers of children receiving inpatient care, aged 12 months to 18 years, newly diagnosed with type 1 diabetes mellitus (T1DM) with or without incidence of diabetic ketoacidosis (DKA) "
46510	KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease	"Adults and children identified with chronic kidney disease (CKD) who are not on renal replacement therapy (RRT) (i.e., not on dialysis or have not received a kidney transplant)&lt;/p&gt;\\r\\n&lt;p class=&quot;Note&quot;&gt;&lt;strong&gt;Note&lt;/strong&gt;: It is beyond the scope of this guideline to address all issues related to children with CKD, given the heterogeneous nature of this group of individuals who range from newborn to post-adolescents, with specific physiological differences within each of those groups."
46648	Diagnosis and management of adults with chronic kidney disease	&lt;ul style=&quot;list-style-type: disc;&quot;&gt;\\r\\n    &lt;li&gt;Adults at increased risk for chronic kidney disease (CKD) &lt;/li&gt;\\r\\n    &lt;li&gt;Adults with CKD&lt;/li&gt;\\r\\n&lt;/ul&gt;
46649	Adult preventive services (ages 18-49)	Adult patients ages 18 to 49 years
46650	Adult preventive services (ages 50 - 65+)	Adult patients ages 50 to 65+ years
46654	Management of overweight and obesity in the adult	&lt;ul style=&quot;list-style-type: disc;&quot;&gt;\\n    &lt;li&gt;Adults 18 years of age or older &lt;/li&gt;\\n    &lt;li&gt;Adults 18 years of age or older with body mass index (BMI) in the following ranges:\\n    &lt;ul style=&quot;list-style-type: disc;&quot;&gt;\\n        &lt;li&gt;BMI &amp;ge;25 &lt;/li&gt;\\n        &lt;li&gt;BMI &amp;ge;30 or &amp;ge;27 with other risk factors or diseases &lt;/li&gt;\\n        &lt;li&gt;BMI &amp;ge;40 or BMI &amp;ge;35 with uncontrolled comorbid conditions &lt;/li&gt;\\n    &lt;/ul&gt;\\n    &lt;/li&gt;\\n&lt;/ul&gt;
46655	Management of diabetes mellitus	Patients 18 to 75 years of age with type 1 or type 2 diabetes mellitus
46660	"The 2013 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension"	"Canadian adult population with or at risk for hypertension, including patients with hypertension associated with ischemic heart disease, heart failure, stroke, left ventricular hypertrophy, nondiabetic kidney disease, renovascular disease, diabetes mellitus, and secondary hypertension due to endocrine causes such as hyperaldosteronism and pheochromocytoma&lt;/p&gt;\\r\\n&lt;p class=&quot;Note&quot;&gt;&lt;strong&gt;Note&lt;/strong&gt;: These recommendations focus on adult care and are predominantly targeted toward primary care providers. For issues related to the diagnosis and evaluation of high blood pressure in children and adolescents, the reader is referred to separate guidelines."
46910	2012 update of the Canadian Cardiovascular Society guidelines for the diagnosis and treatment of dyslipidemia for the prevention of cardiovascular disease in the adult	Adult patients in the Canadian population at risk of dyslipidemia and cardiovascular disease
46926	Dapagliflozin in combination therapy for treating type 2 diabetes	"Adults over 18 years old with type 2 diabetes whose glycaemic control, with metformin or insulin, with or without a second oral agent, and together with diet and exercise, is not satisfactory"
46946	Ottawa Panel evidence-based clinical practice guidelines for aerobic walking programs in the management of osteoarthritis	Adults 40 years old and older who were diagnosed with osteoarthritis (OA) of the knee
47019	Myocardial infarction with ST-segment elevation. The acute management of myocardial infarction with ST-segment elevation	"&lt;ul style=&quot;list-style-type: disc;&quot;&gt;\\r\\n    &lt;li&gt;Adults (18 years or older) in the National Health Service in England and Wales believed to be having spontaneous onset of ST-segment-elevation myocardial infarction (STEMI) (types 1 and 3 of the \\\'universal definition of myocardial infarction\\\' categories) &lt;/li&gt;\\r\\n    &lt;li&gt;Adults in the National Health Service in England and Wales with suggestive symptoms of spontaneous onset of STEMI, but whose electrocardiogram may be difficult to interpret because of the presence of left bundle branch block or permanent pacing &lt;/li&gt;\\r\\n    &lt;li&gt;Where data exist, guidance will address differences between specific populations, such as older adults, women and people from ethnic minorities &lt;/li&gt;\\r\\n    &lt;li&gt;Particular attention will be paid to people with STEMI who remain unconscious following resuscitation &lt;/li&gt;\\r\\n&lt;/ul&gt;\\r\\n&lt;p class=&quot;note&quot;&gt;&lt;strong&gt;Note&lt;/strong&gt;: This guideline does not include the following populations or issues:&lt;/p&gt;\\r\\n&lt;ul class=&quot;contentListFont&quot;&gt;\\r\\n    &lt;li&gt;Children and young people (younger than 18 years) &lt;/li&gt;\\r\\n    &lt;li&gt;Patients initially suspected as having STEMI once this diagnosis is excluded (for example, on cardiac catheterisation) &lt;/li&gt;\\r\\n    &lt;li&gt;Patients once a diagnosis of STEMI has been excluded (for example, as a complication of coronary revascularisation) &lt;/li&gt;\\r\\n    &lt;li&gt;Management of suspected brain injury in those with STEMI who have suffered cardiac arrest &lt;/li&gt;\\r\\n    &lt;li&gt;Management of STEMI after hospital discharge, including post-myocardial infarction treatments &lt;/li&gt;\\r\\n&lt;/ul&gt;"
47027	Obesity prevention and management	Patients aged 2 years and older seen in primary care
47030	Heart failure in adults	Adult patients age 18 years and older with suspected heart failure
47037	British Thoracic Society guideline on pulmonary rehabilitation in adults	"Adults with chronic respiratory disease, focusing on chronic obstructive pulmonary disease (COPD)&lt;/p&gt;\\r\\n&lt;p class=&quot;Note&quot;&gt;&lt;strong&gt;Note&lt;/strong&gt;: Children are not covered by this guideline."
47068	Optimal use recommendations for second- and third-line therapy for patients with type 2 diabetes	&lt;ul style=&quot;list-style-type: disc;&quot;&gt;\\r\\n    &lt;li&gt;Patients with type 2 diabetes inadequately controlled with metformin monotherapy &lt;/li&gt;\\r\\n    &lt;li&gt;Patients with type 2 diabetes inadequately controlled with metformin and sulfonylurea combination therapy &lt;/li&gt;\\r\\n&lt;/ul&gt;\\r\\n&lt;p class=&quot;Note&quot;&gt;&lt;strong&gt;Note&lt;/strong&gt;: Inadequate control was defined as glycated hemoglobin (A1C) &amp;gt;6.5% or fasting plasma glucose &amp;gt;7 mmol/L or two-hour post-prandial glucose &amp;gt;10 mmol/L.&lt;/p&gt;
47084	Heart failure - systolic dysfunction	Adult patients with left ventricular systolic dysfunction
47108	Adults with systolic heart failure	"Adults with suspected or diagnosed left-ventricular systolic dysfunction, including heart failure"
47151	Long-term medical management of the pediatric patient after liver transplantation: 2013 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation	Children and adolescents who have undergone liver transplantation
47289	Screening and management of hypercholesterolemia	&lt;ul style=&quot;list-style-type: disc;&quot;&gt;\\r\\n    &lt;li&gt;Males &amp;ge;35 years of age &lt;/li&gt;\\r\\n    &lt;li&gt;Females &amp;ge;45 years of age &lt;/li&gt;\\r\\n    &lt;li&gt;Males and females &amp;ge;18 years of age with risk factors &lt;/li&gt;\\r\\n&lt;/ul&gt;
47315	Adult depression in primary care	Adults age 18 and over with suspected or established diagnosis of major depression and persistent depressive disorder&lt;/p&gt;\\r\\n&lt;p class=&quot;Note&quot;&gt;&lt;strong&gt;Note&lt;/strong&gt;: This guideline does not address the pediatric population.
47343	2013 ACCF/AHA guideline for the management of heart failure. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines	"Adults with heart failure (HF) &lt;/p&gt;\\r\\n&lt;p class=&quot;Note&quot;&gt;&lt;strong&gt;Note&lt;/strong&gt;: Although of increasing importance, HF in children and congenital heart lesions in adults are not specifically addressed in this guideline."
47352	Clinical practice guideline: non-invasive blood pressure measurement with automated devices	"Emergency department patients of all ages, including pregnant women and patients with hypertension, atrial fibrillation, trauma and hypotension"
47453	"Screening, monitoring, and treatment of stage 1 to 3 chronic kidney disease: a clinical practice guideline from the Clinical Guidelines Committee of the American College of Physicians"	Adults with stage 1 to 3 chronic kidney disease (CKD)
47538	A.S.P.E.N. clinical guidelines: nutrition support of hospitalized adult patients with obesity	Critically Ill or hospitalized non-intensive care unit (ICU) adult patients who have obesity
47543	Diagnosis and treatment of osteoporosis	Adult patients at risk for osteoporosis or with suspected or confirmed osteoporosis&lt;/p&gt;\\r\\n&lt;p class=&quot;Note&quot;&gt;&lt;strong&gt;Note&lt;/strong&gt;: This guideline does not address the pediatric population in which a low bone mass leading to fracture is very rare and pharmacologic intervention is only occasionally indicated.
47559	"Appropriate use criteria for amyloid PET: a report of the Amyloid Imaging Task Force, the Society of Nuclear Medicine and Molecular Imaging, and the Alzheimer\'s Association"	"&lt;ul style=&quot;list-style-type: disc;&quot;&gt;\\r\\n    &lt;li&gt;Patients with persistent or progressive unexplained mild cognitive impairment (MCI) &lt;/li&gt;\\r\\n    &lt;li&gt;Patients satisfying core clinical criteria for possible Alzheimer\\\'s disease (AD) because of unclear clinical presentation, either an atypical clinical course or an etiologically mixed presentation &lt;/li&gt;\\r\\n    &lt;li&gt;Patients with progressive dementia and atypically early age of onset (usually defined as 65 years or less in age) &lt;/li&gt;\\r\\n&lt;/ul&gt;"
47566	Assessment and management of foot ulcers for people with diabetes	Patients (&amp;ge;15 years old) with type 1 and/or type 2 diabetes who have established diabetic foot ulcers
47568	World Gastroenterology Organisation global guideline: obesity	People who are obese
47570	Treatment of anemia in patients with heart disease: a clinical practice guideline from the American College of Physicians	Anemic or iron deficient adult patients with heart disease
47572	Asthma. In: Pulmonary (acute &amp;amp; chronic)&lt;/div&gt;	Workers with asthma
47588	Mental illness &amp;amp; stress	"Workers with occupational stress, major depressive disorder, and other mental disorders"
47592	"Diabetes (type 1, 2, and gestational)"	"Workers with type 1, type 2, and gestational diabetes mellitus"
47681	ACR Appropriateness Criteria&amp;reg; renal failure	Patients with acute or chronic renal failure
47699	KDIGO clinical practice guideline for lipid management in chronic kidney disease	Adults and children with chronic kidney disease (CKD) and dyslipidemia
47700	MI - secondary prevention. Secondary prevention in primary and secondary care for patients following a myocardial infarction	"Adults aged 18 and older who have had a myocardial infarction (MI), either recently or in the past (more than 12 months ago)"
47767	Adapting your practice: treatment and recommendations for patients who are homeless with diabetes mellitus	Homeless adults with diabetes mellitus
47783	Lipid management in adults	Adults age 20 and older who are dyslipidemic
47804	Management and prevention of osteoporosis	&lt;ul style=&quot;list-style-type: disc;&quot;&gt;\\r\\n    &lt;li&gt;Patients at potential risk for osteoporosis &lt;/li&gt;\\r\\n    &lt;li&gt;Patients requiring therapy to reduce high risk of non-traumatic fractures &lt;/li&gt;\\r\\n    &lt;li&gt;Patients with fracture &lt;/li&gt;\\r\\n&lt;/ul&gt;
47805	Primary care diagnosis and management of adults with depression	"&lt;ul style=&quot;list-style-type: disc;&quot;&gt;\\r\\n    &lt;li&gt;Adults 18 years or older with high risk for major depressive disorder, including conditions such as prenatal and postpartum; chronic medication use, disabling illness and/or pain; anxiety &lt;/li&gt;\\r\\n    &lt;li&gt;Individuals diagnosed with significant mood symptoms, particularly those meeting criteria for major depression &lt;/li&gt;\\r\\n&lt;/ul&gt;"
47806	Medical management of adults with osteoarthritis	Adults with clinical suspicion or confirmed diagnosis of osteoarthritis
47807	British HIV Association guidelines for the treatment of HIV-1-positive adults with antiretroviral therapy 2012	Adults with human immunodeficiency virus (HIV) infection or acquired immune deficiency syndrome (AIDS)
47819	American Academy of Orthopaedic Surgeons appropriate use criteria for non-arthroplasty treatment of osteoarthritis of the knee	Adults (ages 19 years and older) who have been diagnosed by a physician with osteoarthritis of the knee and are undergoing treatment&lt;/p&gt;\\r\\n&lt;p class=&quot;Note&quot;&gt;&lt;strong&gt;Note&lt;/strong&gt;: This guideline does not cover asymptomatic patients with inflammatory disorders that are likely causes of knee pain or patients receiving growth factor injections and platelet rich plasma.
47860	Clinical practice guideline on the comprehensive care of people with Alzheimer\'s disease and other dementias	"People affected by dementia, whatever the age of onset of the process, and their relatives and caregivers"
47862	Osteoarthritis. Care and management in adults	"Adults with osteoarthritis&lt;/p&gt;\\r\\n&lt;p class=&quot;Note&quot;&gt;&lt;strong&gt;Note&lt;/strong&gt;: This guideline does not address people with predisposing and associated conditions including:&lt;/p&gt;\\r\\n&lt;ul class=&quot;contentListFont&quot;&gt;\\r\\n    &lt;li&gt;Spinal, neck and back pain &lt;/li&gt;\\r\\n    &lt;li&gt;Crystal arthritis (gout or pseudo-gout) &lt;/li&gt;\\r\\n    &lt;li&gt;Inflammatory arthritis (including rheumatoid arthritis, psoriatic arthritis and the seronegative arthritides) &lt;/li&gt;\\r\\n    &lt;li&gt;Septic arthritis &lt;/li&gt;\\r\\n    &lt;li&gt;Diseases of childhood that predispose to osteoarthritis &lt;/li&gt;\\r\\n    &lt;li&gt;Medical conditions presenting with joint inflammation, such as haemochromatosis &lt;/li&gt;\\r\\n&lt;/ul&gt;&lt;/div&gt;"
47865	Clinical practice guideline for diabetes mellitus type 1	"Children, adolescents and adults (including pregnant women) with diabetes mellitus type 1, assisted in primary and specialty care, both in the intra- and outpatient means within the Spanish National Health System"
47870	Total hip replacement and resurfacing arthroplasty for end-stage arthritis of the hip (review of technology appraisal guidance 2 and 44)	People with pain or disability resulting from end-stage arthritis of the hip for whom non-surgical management has failed
47871	Guidelines for the prevention of stroke in women: a statement for healthcare professionals from the American Heart Association/American Stroke Association	Women with risk factors for stroke
47873	Summary of evidence-based guideline update: prevention of stroke in nonvalvular atrial fibrillation. Report of the Guideline Development Subcommittee of the American Academy of Neurology	"&lt;ul style=&quot;list-style-type: disc;&quot;&gt;\\r\\n    &lt;li&gt;Patients with known nonvalvular atrial fibrillation (NVAF) &lt;/li&gt;\\r\\n    &lt;li&gt;Patients with cryptogenic stroke without known NVAF (i.e., patients with occult NVAF) &lt;/li&gt;\\r\\n&lt;/ul&gt;"
47874	"Presentation, diagnosis, and medical management of heart failure in children: Canadian Cardiovascular Society guidelines"	Children (aged 0-18 years) with undiagnosed heart disease and symptoms of possible heart failure (HF) and children with confirmed HF
47898	Diabetes and pregnancy: an Endocrine Society clinical practice guideline	"&lt;ul style=&quot;list-style-type: disc;&quot;&gt;\\r\\n    &lt;li&gt;Patients with diabetes during preconception, pregnancy, and postpartum &lt;/li&gt;\\r\\n    &lt;li&gt;Pregnant women without known pre-existing diabetes &lt;/li&gt;\\r\\n&lt;/ul&gt;"
47915	Evidence-based clinical practice guideline: eye care of the patient with diabetes mellitus	Patients of any age with diabetes mellitus
47920	Management of chronic kidney disease	Adults with chronic kidney disease (CKD)
48052	"Clinical practice guidelines for the management of overweight and obesity in adults, adolescents and children in Australia"	"&lt;ul style=&quot;list-style-type: disc;&quot;&gt;\\r\\n    &lt;li&gt;Adults and adolescents aged more than 18 years who have a body mass index (BMI) greater than 25 kg/m&lt;sup&gt;2&lt;/sup&gt; and are at risk of, or have, one or more overweight or obesity-related comorbidities &lt;/li&gt;\\r\\n    &lt;li&gt;Children and adolescents aged between 2 and 18 years who have a BMI greater than the 85th percentile according to the United States Centers for Disease Control and Prevention (US-CDC) or World Health Organization (WHO) percentile charts &lt;/li&gt;\\r\\n    &lt;li&gt;Infants and children under 2 years of age who demonstrate rapid weight gain as assessed using WHO growth charts &lt;/li&gt;\\r\\n&lt;/ul&gt;"
48117	Guidelines for the management of absolute cardiovascular disease risk	Australian adults aged 45 years and over (35 years for Aboriginal and Torres Strait Islander peoples) who have no previous history of cardiovascular disease (CVD)
48194	Screening and management of lipids	Adults 20 to 79 years of age without familial or severe dyslipidemias or chronic kidney disease (CKD)
48196	Essential hypertension	Adults age 18 and older
48208	The official positions of the International Society for Clinical Densitometry: body composition analysis reporting	"Individuals at risk of very low lean body mass, very low fat mass, or very high fat mass (either regionally or systemically)"
48209	The official positions of the International Society for Clinical Densitometry: acquisition of dual-energy x-ray absorptiometry body composition and considerations regarding analysis and repeatability of measures	"Individuals at risk of very low lean body mass, very low fat mass, or very high fat mass (either regionally or systemically)"
48210	The official positions of the International Society for Clinical Densitometry: indications of use and reporting of DXA for body composition	"Individuals at risk of very low lean body mass, very low fat mass, or very high fat mass (either regionally or systemically), including people living with human immunodeficiency virus (HIV), obesity, post-bariatric surgery or weight loss, and sarcopenia"
48211	Indications of DXA in women younger than 65 yr and men younger than 70 yr: the 2013 official positions	Women and men at risk of having low bone mass sufficient to warrant medical intervention
48212	The official positions of the International Society for Clinical Densitometry: vertebral fracture assessment	"Patients with, or at risk for, vertebral fracture"
48213	2013 International Society for Clinical Densitometry position development conference: Task Force on Normative Databases	"Women and men with, or at risk for, osteoporosis and osteoporosis-related fracture"
48221	Secondary prevention of ischemic heart disease and stroke in adults	"Adults with ischemic vascular disease (IVD), including:&lt;/p&gt;\\n&lt;ul style=&quot;list-style-type: disc;&quot;&gt;\\n    &lt;li&gt;Ischemic heart disease (IHD) &amp;ndash; both angina (stable or unstable) and myocardial infarction (ST segment elevation [STEMI] and non-ST segment elevation [NSTEMI]) &lt;/li&gt;\\n    &lt;li&gt;Ischemic stroke and transient ischemic attack (TIA) &lt;/li&gt;\\n&lt;/ul&gt;&lt;/div&gt;"
48261	Management of acute atrial fibrillation and atrial flutter in non-pregnant hospitalized adults	"Adult non-pregnant hospitalized patients with atrial fibrillation and atrial flutter&lt;/p&gt;\\r\\n&lt;p class=&quot;Note&quot;&gt;&lt;strong&gt;Note&lt;/strong&gt;: These guidelines are applicable to all inpatients with notable exception of patients on the Cardiology, Cardiac Intensive Care or Cardiac Surgery Services."
48267	2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines	Adult patients with suspected or confirmed valvular heart disease (VHD) &lt;/p&gt;\\n&lt;p class=&quot;Note&quot;&gt;&lt;strong&gt;Note&lt;/strong&gt;: Management of patients with congenital heart disease and infants and children with valve disease are not addressed in this guideline.
48280	ACR Appropriateness Criteria&amp;reg; chest pain suggestive of acute coronary syndrome	Patients with chest pain suggestive of acute coronary syndrome
48285	ACR Appropriateness Criteria&amp;reg; dementia and movement disorders	Patients with dementia and movement disorders
48333	Atrial fibrillation: the management of atrial fibrillation	"Adults (18 years or older) with atrial fibrillation (AF), including paroxysmal (recurrent), persistent and permanent AF, and atrial flutter&lt;/p&gt;\\r\\n&lt;p class=&quot;Note&quot;&gt;&lt;strong&gt;Note&lt;/strong&gt;: This guideline does not apply to people with congenital heart disease precipitating AF."
48335	Implantable cardioverter defibrillators and cardiac resynchronisation therapy for arrhythmias and heart failure (review of TA95 and TA120)	"&lt;ul style=&quot;list-style-type: disc;&quot;&gt;\\n    &lt;li&gt;People at increased risk of sudden cardiac death as a result of ventricular arrhythmias despite optimal pharmacological treatment &lt;/li&gt;\\n    &lt;li&gt;People with heart failure as a result of left ventricular systolic dysfunction and cardiac dyssynchrony despite optimal pharmacological treatment &lt;/li&gt;\\n    &lt;li&gt;People with both conditions described above &lt;/li&gt;\\n&lt;/ul&gt;\\n&lt;p class=&quot;Note&quot;&gt;&lt;strong&gt;Note&lt;/strong&gt;: In practice these are not distinct populations and there is considerable overlap between the groups, such that people with heart failure due to left ventricular systolic dysfunction are at risk of sudden cardiac death from ventricular arrhythmia.&lt;/p&gt;"
48337	2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines	Adults &amp;ge;21 years of age at risk of or with atherosclerotic cardiovascular disease (ASCVD) 
48338	2013 AHA/ACC guideline on lifestyle management to reduce cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines	Adults 18 years of age and older
48339	2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society	Overweight and obese adult patients
48340	2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines	"Adult population without clinical signs or symptoms of atherosclerotic cardiovascular disease (ASCVD)&lt;/p&gt;\\n&lt;p class=&quot;Note&quot;&gt;&lt;strong&gt;Note&lt;/strong&gt;: These recommendations do not apply to those with clinically manifest ASCVD, who require secondary prevention approaches, or to highly-selected patient subgroups, such as those with symptoms suggestive of cardiovascular disease (CVD), who require diagnostic strategies rather than risk assessment. Furthermore, these recommendations were not developed for use in specific subgroups of asymptomatic individuals at unusually high risk, such as those with genetically determined extreme values of traditional risk factors (e.g., patients with familial hypercholesterolemia)."
48368	Guidelines for laparoscopic peritoneal dialysis access surgery	Patients with renal failure
48404	Prasugrel with percutaneous coronary intervention for treating acute coronary syndromes (review of technology appraisal guidance 182)	"Patients with acute coronary syndrome (unstable angina [UA], non-ST-segment-elevation myocardial infarction [NSTEMI] or ST-segment-elevation myocardial infarction [STEMI]) undergoing primary or delayed percutaneous coronary intervention "
48406	Lipid modification: cardiovascular risk assessment and the modification of blood lipids for the primary and secondary prevention of cardiovascular disease	&lt;ul style=&quot;list-style-type: disc;&quot;&gt;\\n    &lt;li&gt;Adults (aged 18 years and older) without established cardiovascular disease (CVD) &lt;/li&gt;\\n    &lt;li&gt;Adults with type 1 diabetes &lt;/li&gt;\\n    &lt;li&gt;Adults with type 2 diabetes &lt;/li&gt;\\n    &lt;li&gt;Adults with chronic kidney disease (CKD) &lt;/li&gt;\\n    &lt;li&gt;Adults (aged 18 and older) with established CVD &lt;/li&gt;\\n    &lt;li&gt;The following special groups are considered:\\n    &lt;ul style=&quot;list-style-type: disc;&quot;&gt;\\n        &lt;li&gt;People from black and minority ethnic groups &lt;/li&gt;\\n        &lt;li&gt;People with a family history of CVD &lt;/li&gt;\\n        &lt;li&gt;People from low socioeconomic groups &lt;/li&gt;\\n        &lt;li&gt;People older than 75 &lt;/li&gt;\\n        &lt;li&gt;Women &lt;/li&gt;\\n        &lt;li&gt;People with autoimmune disease &lt;/li&gt;\\n        &lt;li&gt;People with serious mental illness &lt;/li&gt;\\n    &lt;/ul&gt;\\n    &lt;/li&gt;\\n&lt;/ul&gt;\\n&lt;p class=&quot;Note&quot;&gt;&lt;strong&gt;Note&lt;/strong&gt;: The guideline does not cover:&lt;/p&gt;\\n&lt;ul class=&quot;Note&quot;&gt;\\n    &lt;li&gt;Children and young people (aged 18 years and younger) &lt;/li&gt;\\n    &lt;li&gt;People with familial hypercholesterolaemia &lt;/li&gt;\\n    &lt;li&gt;People with familial clotting disorders that increase cardiovascular risk &lt;/li&gt;\\n    &lt;li&gt;People with other genetic disorders that increase cardiovascular risk &lt;/li&gt;\\n    &lt;li&gt;People at high risk of CVD or abnormalities of lipid metabolism as a result of endocrine or other secondary disease processes other than diabetes &lt;/li&gt;\\n    &lt;li&gt;People receiving renal replacement therapy &lt;/li&gt;\\n&lt;/ul&gt;
48457	"International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma"	Adults and children with severe asthma
48461	VA/DoD clinical practice guideline for screening and management of overweight and obesity	"Adults (men and women who are &amp;gt;18 years old) who are eligible for care in the Veterans Affairs (VA) or Department of Defense (DoD) health care delivery system&lt;/p&gt;\\n&lt;p class=&quot;Note&quot;&gt;&lt;strong&gt;Note&lt;/strong&gt;: This guideline does not provide recommendations for the treatment of children, adolescents, or pregnant/lactating women."
48530	VA/DoD clinical practice guideline for the non-surgical management of hip and knee osteoarthritis	Any adult patient eligible for care in the Veterans Health Administration (VHA) or Department of Defense (DoD) healthcare delivery systems who has chronic joint complaints in the absence of acute trauma
48533	"Measuring fractional exhaled nitric oxide concentration in asthma: NIOX MINO, NIOX VERO and NObreath"	"People with clinical characteristics suggestive of asthma, including:&lt;/p&gt;\\n&lt;ul style=&quot;list-style-type: disc;&quot;&gt;\\n    &lt;li&gt;Any patient 5 years old or older presenting to primary care with symptoms of asthma &lt;/li&gt;\\n    &lt;li&gt;People with clinical characteristics suggestive of asthma who are difficult to diagnose &lt;/li&gt;\\n    &lt;li&gt;Patients who may experience different outcomes from the use of fractional exhaled nitric oxide (FeNO) when compared to the main population under assessment defined as smokers, the elderly and pregnant women &lt;/li&gt;\\n&lt;/ul&gt;&lt;/div&gt;"
48542	"New generation cardiac CT scanners (Aquilion ONE, Brilliance iCT, Discovery CT750 HD and Somatom Definition Flash) for cardiac imaging in people with suspected or known coronary artery disease in whom imaging is difficult with earlier generation CT scanners"	&lt;ul style=&quot;list-style-type: disc;&quot;&gt;\\n    &lt;li&gt;Adults (18 years or older) with suspected coronary artery disease in whom imaging with earlier generation computed tomography (CT) is difficult and with a 10% to 29% pre-test likelihood of coronary artery disease &lt;/li&gt;\\n    &lt;li&gt;Adults (18 years or older) with known coronary artery disease in whom imaging with earlier generation CT is difficult and in whom revascularisation is being considered &lt;/li&gt;\\n&lt;/ul&gt;
48544	Diagnosis and management of type 2 diabetes mellitus in adults	Adult patients age 18 and older with prediabetes and type 2 diabetes mellitus (T2DM)&lt;/p&gt;\\n&lt;p class=&quot;Note&quot;&gt;&lt;strong&gt;Note&lt;/strong&gt;: The management of gestational diabetes and T2DM in patients who are pregnant is excluded from the scope of this guideline. Please refer to the National Guideline Clearinghouse (NGC) summary of the Institute for Clinical Systems Improvement (ICSI) guideline &lt;a href=&quot;/content.aspx?id=38256&quot; title=&quot;Guideline #9283&quot;&gt;Routine prenatal care&lt;/a&gt; for information relating to gestational diabetes and T2DM in patients who are pregnant.
48562	Atrial fibrillation and heart valve disease: self-monitoring coagulation status using point-of-care coagulometers (the CoaguChek XS system and the INRatio2 PT/INR monitor)	Children and adults on long-term vitamin K antagonist therapy who have atrial fibrillation or heart valve disease
48565	"Bipolar disorder: the assessment and management of bipolar disorder in adults, children and young people in primary and secondary care"	"Children, young people and adults with suspected or diagnosed bipolar disorder, including bipolar I, bipolar II, mixed affective and rapid cycling disorders"
48752	Acute heart failure: diagnosing and managing acute heart failure in adults	"Adults (aged 18 years or older) who have a diagnosis of acute heart failure, or have possible acute heart failure, or are being investigated for acute heart failure&lt;/p&gt;\\n&lt;p class=&quot;Note&quot;&gt;&lt;strong&gt;Note&lt;/strong&gt;: Specific consideration is given to subgroups with pulmonary oedema, cardiogenic shock, acute right-sided heart failure or acute decompensated heart failure."
48754	"Myocardial infarction (acute): early rule out using high-sensitivity troponin tests (Elecsys Troponin T high-sensitive, ARCHITECT STAT High Sensitive Troponin-I and AccuTnI+3 assays)"	"People presenting with acute chest pain and suspected, but not confirmed, non-ST-segment elevation myocardial infarction (NSTEMI)"
48761	Adult weight management evidence-based nutrition practice guideline	Overweight and obese adults (19 years and older)
48762	Prevention of type 2 diabetes evidence-based nutrition practice guideline	"Adolescent (13 to 18 years) and adult (19 and older) individuals who are at high risk for type 2 diabetes, such as individuals with prediabetes and adults with metabolic syndrome"
48783	"Multisociety consensus quality improvement guidelines for intraarterial catheter-directed treatment of acute ischemic stroke from the American Society of Neuroradiology, Canadian Interventional Radiology Association, Cardiovascular and Interventional Radiology Society of Europe, Society for Cardiac Angiography and Interventions, Society of Interventional Radiology, Society of NeuroInterventional Surgery, European Society of Minimally Invasive Neurological Therapy, Society of Vascular and Interventional Neurology"	Patients with acute ischemic stroke undergoing endovascular treatment with intraarterial thrombolytic agents or mechanical revascularization
48784	The Clinical Pharmacogenetics Implementation Consortium guideline for &lt;em&gt;SLCO1B1&lt;/em&gt; and simvastatin-induced myopathy: 2014 update	Patients who are on or who are being considered for simvastatin therapy
48858	VA/DoD clinical practice guideline for the diagnosis and management of hypertension in the primary care setting	"Adults (men and women) who are eligible for care in the Department of Veterans Affairs (VA) and Department of Defense (DoD) healthcare delivery system, including veterans as well as deployed and non-deployed active duty service members&lt;/p&gt;\\n&lt;p class=&quot;Note&quot;&gt;&lt;strong&gt;Note&lt;/strong&gt;: This guideline does not provide recommendations for the management of hypertension (HTN) in pregnant women, peri-operative/inpatient adults, children or adolescents."
48872	"Obesity: identification, assessment and management of overweight and obesity in children, young people and adults"	"Adults, children and young people (aged 2 years or older) who are overweight or obese, including those with established comorbidities, and those with or without risk factors for other medical conditions&lt;/p&gt;\\n&lt;p&gt;The following special groups, who have a high rate of morbidity resulting from being obese, are considered when there is good evidence of effectiveness of separate interventions targeted at these groups:&lt;/p&gt;\\n&lt;ul style=&quot;list-style-type: disc;&quot;&gt;\\n    &lt;li&gt;Black and minority ethnic groups &lt;/li&gt;\\n    &lt;li&gt;People from lower socio-economic groups &lt;/li&gt;\\n    &lt;li&gt;Young people &lt;/li&gt;\\n    &lt;li&gt;People with learning disabilities &lt;/li&gt;\\n    &lt;li&gt;Older people &lt;/li&gt;\\n    &lt;li&gt;People with type 2 diabetes &lt;/li&gt;\\n&lt;/ul&gt;\\n&lt;p class=&quot;Note&quot;&gt;&lt;strong&gt;Note&lt;/strong&gt;: The guideline does not cover people of a healthy weight, pregnant women or children under 2 years of age."
48950	VA/DoD clinical practice guideline for the management of dyslipidemia for cardiovascular risk reduction	"Patients at risk for cardiovascular disease (CVD)&lt;/p&gt;\\n&lt;p class=&quot;Note&quot;&gt;&lt;strong&gt;Note&lt;/strong&gt;: The patient population of interest for this Clinical Practice Guideline (CPG) is adults (men and women), that are eligible for care in the Veterans Health Administration (VHA) and Department of Defense (DoD) health care delivery system. Patients with severe systolic chronic heart failure (CHF), end stage renal disease (ESRD) and on dialysis, or a limited life expectancy are excluded from this CPG. This CPG does not provide recommendations for the management of dyslipidemia in children or adolescents."
48951	VA/DoD clinical practice guideline for the management of chronic kidney disease in primary care	"Patients with chronic kidney disease (CKD) stages 1-4&lt;/p&gt;\\n&lt;p class=&quot;Note&quot;&gt;&lt;strong&gt;Note&lt;/strong&gt;: The patient population of interest for this Clinical Practice Guideline (CPG) is adults (men and women), that are eligible for care in the Veterans Health Administration (VHA) and Department of Defense (DoD) health care delivery system. It includes deployed and non-deployed Veterans as well as active duty Service Members. This CPG does not provide recommendations for the management of CKD in children or adolescents."
48952	VA/DoD clinical practice guideline for the management of chronic obstructive pulmonary disease	"Adults with a diagnosis or a suspicion of chronic obstructive pulmonary disease (COPD)&lt;/p&gt;\\n&lt;p class=&quot;Note&quot;&gt;&lt;strong&gt;Note&lt;/strong&gt;: The patient population of interest is adults (men and women) who are eligible for care in the Veterans Health Administration (VHA) or the Department of Defense (DoD) health care delivery systems. Patients with bronchiectasis, asthma, cystic fibrosis, or other chronic lung diseases but without COPD are not considered in this clinical practice guideline."
49013	Recommendations for prevention of weight gain and use of behavioural and pharmacological interventions to manage overweight and obesity in adults in primary care	&lt;ul style=&quot;list-style-type: disc;&quot;&gt;\\n    &lt;li&gt;Apparently healthy adults &amp;ge;18 years who present to primary care providers &lt;/li&gt;\\n    &lt;li&gt;Adults &amp;ge;18 years who are overweight or obese (body mass index [BMI] 25&amp;ndash;39.9) &lt;/li&gt;\\n&lt;/ul&gt;\\n&lt;p class=&quot;Note&quot;&gt;&lt;strong&gt;Note&lt;/strong&gt;: See the &quot;Major Recommendations&quot; field for populations not included for specific recommendations.&lt;/p&gt;
49117	Maintaining a healthy weight and preventing excess weight gain among adults and children	Children (after weaning) and adults &lt;/p&gt;\\n&lt;p class=&quot;Note&quot;&gt;&lt;strong&gt;Note&lt;/strong&gt;: The guideline does not cover the particular needs of women during pregnancy or people who have conditions that increase their risk of being overweight or obese.
49123	Rivaroxaban for preventing adverse outcomes after acute management of acute coronary syndrome	Adults after acute management of an acute coronary syndrome (ACS) with elevated cardiac biomarkers
49124	Empagliflozin in combination therapy for treating type 2 diabetes	Patients with type 2 diabetes
49133	Prevention of acute exacerbations of COPD: American College of Chest Physicians and Canadian Thoracic Society guideline	Patients with chronic obstructive pulmonary disease (COPD)
6382	"Device selection and outcomes of aerosol therapy: evidence-based guidelines: American College of Chest Physicians/American College of Asthma, Allergy, and Immunology"	"Patients of all ages with asthma and chronic obstructive pulmonary disease (COPD) in varied clinical settings (outpatient, emergency department, hospitalized inpatient, or intensive care settings)"
8097	American College of Chest Physicians guidelines for the prevention and management of postoperative atrial fibrillation after cardiac surgery	Patients undergoing cardiac surgery
